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Abstract 
During embryonic development, adipocytes emerge from microvasculature [1, 2]. Lineage-­‐tracing	  studies	  in	  mice	  have	  shown	  that	  adipocyte	  progenitors	  reside	  in	  the	  adipose	  tissue	  capillaries[3-6]. However, the direct evidence of an association between 
adipocyte progenitors and vasculature in humans is lacking. A specific class of 
adipocytes (brown and beige/brite) expresses the uncoupling protein 1 (UCP1), which 
consumes glucose and fatty acids to generate heat[7-9]. The abundance of UCP1-
containing adipocytes correlates with a lean metabolically healthy phenotype in 
human[10, 11]. However, a causal relationship between the presence of these cells and 
metabolic benefits in human is not clear.  
In this thesis, I report human adipocyte progenitors proliferate in response to pro-
angiogenic factors in association with adipose capillary networks in-vitro. The capillary-
derived adipocytes transform from being UCP1-negative to positive upon adenylate 
cyclase activation, a defining feature of the brite/beige phenotype. Activated cells have 
denser, round mitochondria with UCP1 protein, and display uncoupled respiration. When 
implanted into NOD-scid IL2rgnull (NSG) mice, the adipocytes can form a vascularized 
fat pad that induces vascularization and becomes integrated into mouse circulatory 
system. In normal or high fat diet-fed NSG mice, activated brite/beige adipocytes 
enhance systemic glucose tolerance and improved hepatic steatosis, thus providing 
evidence for their potential therapeutic use. The adipocytes also express neuroendocrine 
and secretory factors such as Interleukin-33, proprotein convertase PCSK1 and 
proenkephalin PENK, which are correlated with human obesity. Finally, analyses on 
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single-cell clones of capillary-sprout cells reveal the existence of diverse adipogenic 
progenitor populations. Further characterization of the clones will define the identifying 
features of the diverse adipocyte progenitor types that exist in human adipose tissue. 
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CHAPTER I: Introduction 
[1, 2]. [3-6]. [7-9]. [10, 11]. 	  
The role of adipose tissues in whole-body energy balance and metabolic health  
Glucose homeostasis is crucial for the survival of multicellular organisms 
including humans. Despite intermittent food intake, blood glucose levels in human 
remain relatively steady through the day (approximately 5mM). This requires the 
orchestrated play of several organs[12]. Pancreatic β-cells secrete insulin in response to 
the increase of glucose after eating. Insulin then promotes glucose uptake in 
adipose tissue and muscle while inhibiting liver glucose production. In the fasting state, 
circulating glucose levels decrease, by which pancreatic α-cells release glucagon. 
Glucagon stimulates the breakdown of glycogen in the liver to produce glucose and 
increases synthesis of glucose from pyruvate and other substrates, thus stabilizing glucose 
levels[13]. Adipocytes release fatty acids into the circulation for fuel when glucose is 
limited. Fatty acids are generated from triacylglycerols, which hold more energy per unit 
mass than carbohydrates do[14].  
Energy storage and utilization, which is directly associated with the function of 
adipose tissue, plays an essential role in the development of metabolic diseases such as 
type 2 diabetes, cardiovascular disease, osteoarthritis and fatty liver disease[15]. Failure 
of adipose expansion can lead to the disturbed balance of glucose homeostasis and insulin 
resistance. A-ZIP/F-1 fat-less mice develop severe insulin resistance, which can be 
attributed to the impaired insulin action in liver and muscle[16]. On the other hand, there 
are severely obese individuals who are protected from the development of insulin 
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resistance or metabolic diseases[17], which implies that proper storage of surplus 
nutrients is important to achieve insulin-glucose homeostasis.  
It is also noteworthy that the location of fat storage is important. Pear-shaped 
obesity with expanded subcutaneous adipose tissues is typically protective from 
metabolic complications and associated with metabolic health[18, 19]. In contrast, apple-
shaped obesity accumulates visceral adipose tissues, resulting in deleterious 
consequences[19-21]. Storing lipids in proper adipose depots (subcutaneous) while 
sequestering them from other non-adipose tissues, such as the liver, muscle, heart, and 
pancreatic-islets prevents lipotoxicity and consequent insulin resistance[22] Lipotoxicity 
refers to the deleterious effects of lipid accumulation in peripheral tissues when the 
supply of nutrient exceeds the capacity of adipose tissue. Unger reviewed in 2002 that 
lipotoxicity of pancreatic β-cells, myocardium and skeletal muscle results, respectively, 
in type 2 diabetes, cardiomyopathy and insulin resistance. Spilling-over fatty acids can 
enter harmful pathways such as ceramide production, which causes apoptosis of lipid-
laden cells including β-cells and cardiomyocytes[23]. Chronic exposure to fatty acids 
recapitulates the key features of type 2 diabetes associated with β-cell failure such as β-
cell apoptosis, elevated basal insulin secretion, diminished glucose stimulated insulin 
secretion, reduced insulin content and gene expression, and defective pro-insulin 
processing[24]. 
Adipose tissue grow by both an increase of cell number, hyperplasia, by 
preadipocytes (or adipocyte progenitor) proliferation, and an increase of cell size, 
hypertrophy by accumulating lipids in the cell body[25-27] under required circumstances 
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such as significant calorie intake[28, 29]. Correlation studies between adipocyte size, 
adipocyte number, and plasma insulin levels have revealed that hyperplastic growth, 
which requires proliferation of preadipocytes, is metabolically healthier. Hyperplastic 
expansion is observed more frequently in subcutaneous than in visceral, which might 
explain the metabolic health of obese humans who gained their weight 
subcutaneously[30-33]. Rojas-Rodriguez et al. in our laboratory also showed that 
gestational diabetic patients possessed larger visceral adipocytes and fewer blood 
capillaries in subcutaneous and visceral adipose tissues compared to pregnant women 
with normal glucose tolerance. These results are consistent with those of previous studies 
in non-pregnant humans where large adipocytes are linked to dyslipidemia and glucose-
insulin abnormalities[34, 35]. 
Unlike fat-storing white adipose tissues described so far, brown and brite/beige 
adipose tissues can contribute to metabolic homeostasis by actively consuming 
circulating glucose and fatty acids. These adipocytes contain the mitochondrial 
uncoupling protein (UCP1), and release heat to regulate body temperature[36]. Detailed 
explanation regarding white, brown, and brite/beige adipocytes will be discussed later. 
Adipose tissues play multiple essential roles in regulating metabolism and energy 
homeostasis. Thus, insights on mechanisms that harness the expansion and function of 
adipocytes will not only contribute to the basic knowledge of adipocyte biology, but will 
also be useful for potential therapeutic strategies.  
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Angiogenesis and adipocyte progenitors  
A principal mechanism of blood vessel formation is termed angiogenesis. 
Angiogenesis is essential for the development and growth of all tissues to meet the 
demand of gas and nutrient exchange[28]. It is also essential in many biological processes 
in development, adipose tissue expansion, reproduction and wound repair. Due to its 
crucial roles in every tissue, angiogenesis is a highly coordinated process. The main 
cellular components of vessel walls are endothelia cells, forming tight junctions through 
membrane protein vascular endothelial-cadherins. This the tubular structure is coated 
with vascular basement membrane and pericytes, which support the vasomotion and 
regulate of vascular basement membrane and endothelial barrier function[37]. Major 
inducers of angiogenesis include the vascular endothelial growth factor family, 
angiopoietins, transforming growth factors, platelet-derived growth factor, tumor necrosis 
factor-α, interleukins and the fibroblast growth factor family. Vascular endothelial 
growth factor-A is the most potent pro-angiogenic factor identified among the numerous 
angiogenic factors. It stimulates endothelial cells to proliferate, sprout, and form the 
vessel tubes[38-40].  
During embryonic development, angiogenesis occurs before the emergence of 
adipocytes, and then adipocytes arise along the expending vessels[3, 41, 42]. Han et al. 
investigated the postnatal epididymal adipose tissue in mice and showed the co-
localization of blood vessels and newly forming adipocytes. From postnatal day 1 to 4, 
epididymal adipose tissue was composed of various types of progenitor cells lacking 
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adipogenic differentiation capacity when tested in vitro. However, after day 4 the 
progenitor cells of epididymal adipose tissue obtained their adipogenic differentiation 
capacity and the impairment of the vascular endothelial growth factor/ vascular 
endothelial growth factor receptor 2 signaling pathway blocked adipogenesis[3]. 
Supporting the notion of interdependency between angiogenesis and adipogenesis, onset 
of obesity in mice correlates with an increase in micro-vessel formation[43]. In contrast, 
inhibition of angiogenesis in adipose tissue by inhibitors of endothelial cell proliferation 
(TNP-470, angiostatin, endostatin) or calorie restriction reduced body weight gain and fat 
mass in animals, suggesting neovascularization is mandatory for adipose tissue expansion 
in adults as well[44]. The associated growth of adipocytes with blood vessels has been 
partially explained by the observations that adipocyte precursors reside in the adipose 
tissue vasculature[5, 45, 46]. This result is further supported by the findings that a peptide 
inducing apoptosis of adipose tissue endothelial cells blunted weight gain in mice and 
primates with high fat diet feeding[47, 48].  
Multiple studies including Tran et al. from our laboratory illustrated the 
juxtaposition between preadipocytes and vasculature by utilizing lineage-tracing 
experiments. Results suggest that preadipocytes might emerge from the vasculature or 
from the endothelial cell or pericyte themselves [5, 45, 49, 50]. Using genetically marked 
mice, Tang et al. indicated that the stromal vascular compartment of mouse adipose 
tissues contains peroxisome proliferator-activated receptor gamma (PPARγ)-expressing 
cells that divide, travel along, and notably repopulate the stromal vascular fraction, 
amplifying the population that contributes to adipocyte generation[5]. Gupta et al. labeled 
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committed murine adipose progenitors by marking Zfp423, a gene controlling 
preadipocyte determination, with green fluorescent protein (GFP). The GFP-expressing 
population from subcutaneous or visceral adipose tissue was stably committed to 
preadipocytes that undergo robust adipogenesis. Immunohistochemistry for Zfp423-GFP 
expression verified a perivascular origin of adipocyte progenitors in both white and 
brown adipose depots. Unexpectedly, a subset of endothelial cells also expressed GFP, 
suggesting a contribution of endothelial cells to the adipose lineage[6]. These results are 
consistent with the findings from our laboratory by Tran et al. where lineage tracing 
experiments showed the vascular endothelial cadherin promoter-driven reporter was 
expressed not only in endothelial cells but also in progenitors and white and brown 
adipocytes. Moreover, in response to PPARγ activation by rosiglitazone, endothelial 
characteristics of human adipose sprouting cells were progressively lost while sprout 
cells started to form structurally and biochemically defined adipocytes[49]. Suggested 
markers for the adipocyte progenitors in rodents include pericyte markers and stem cell 
markers [5, 51]. As Tang et al. reported the peri-vascular origin of preadipocytes, the 
authors also confirm the expression of pericyte markers (NG2, SMA, PDFGR β) and Sca-
1 on PPARγ-expressing preadipocytes[5]. In the same month, Rodeheffer et al. also 
identified a series of adipocyte progenitor markers in mice, which include CD24, CD29, 
CD34, and Sca-1. The authors utilized fluorescence-activated cell sorting on mouse 
adipose tissue stromal vascular fraction in combination with an in vivo transplantation to 
show early adipocyte precursor cells reside in the adipose vascular stroma[51]. 
Despite the extensive studies on the characteristics of adipocyte progenitors in 
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mice, our knowledge of human adipocyte progenitors is limited due to the technical 
restrictions of humans (e.g. lineage-tracing). Moreover, insufficient understanding of the 
biology regarding the growth and differentiation of human adipocyte progenitors made it 
almost impossible for researchers to isolate them as experimental materials. Previous 
reports have also shown that cells derived from the stromal vascular fraction, also called 
adipose-derived stem cells from mice and humans can differentiate into adipocytes[52, 
53]. However, the capacity of adipose-derived stem cells to differentiate remained low in 
several protocols[54-56]. Thus, the identity of the human adipocyte progenitor cells 
remains unknown. In this thesis, I describe the efforts we have made in our laboratory to 
overcome these limitations by exploiting our knowledge of the interdependency between 
angiogenesis and adipogenesis.  
 
Thermogenic Fat cells: Brown and Brite/Beige Adipocytes 
Brown adipose cells have the capacity to consume glucose and fat to produce 
heat, dissipating energy rather than making ATP. The uncoupling protein 1 (UCP1) 
localizes at the inner mitochondrial membrane of brown adipocytes and mediates this 
thermogenic function. UCP1 dissipates the proton gradient generated by the electron 
transport chain. This leak of protons reduces mitochondrial inner membrane potential, 
which in turn boosts substrate oxidation and results in the generation of heat[57, 58]. 
Brown fat cells express high amounts of constitutive UCP1 even under non-stimulated 
conditions. 
In mice, the major brown adipose tissue depots include the interscapular, axillary, 
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and cervical brown adipose tissue that developed to generate heat to protect newborns 
from cold exposure. The sympathetic nervous system intimately regulates both the 
growth and thermogenic function of brown adipose tissue. Brown adipocytes get 
innervated by sympathetic fibers upon cold exposure, releasing norepinephrine to directly 
activate thermogenesis[57]. Cold exposure recruits brown adipose tissue through 
stimulating the proliferation and differentiation of brown adipose progenitor cells[59, 60].  
Recruitable brown-like adipocytes that have a multi-locular, mitochondria-dense 
and UCP1-postivie morphology can also be found in white adipose tissue depots[61-63]. 
These ‘‘brite (brown-in-white)’’[64] or ‘‘beige’’[65] adipocytes induce UCP1 expression 
only upon cold exposure or other stimuli, which is a distinctive feature of brite/beige fat. 
Notably, fully stimulated beige adipocytes can gain a comparable level of UCP1 
expression and UCP1-mediated uncoupled respiration as brown adipocytes do [66]. The 
inducibility of beige adipocytes is highly adipose depot specific. In mice, the 
subcutaneous inguinal WAT is most prone to the induction of beige adipocytes, whereas 
the epididymal WAT is fairly resistant to ‘‘browning’’[63]. 
Studies have suggested multiple genes that seem to be preferentially expressed 
either in brown (ZIC1, LHX8 and EVA1) or beige (CD137, TBX1, CITED1) adipocytes 
in rodents and humans[7, 66-68]. The detailed signature of human brown and beige 
adipocyte markers will be discussed in depth in Chapter III. 
The profound interest in brown and brite/beige fat is driven by the potential 
benefits of these cells to counteract obesity and metabolic diseases. Findings from rodent 
studies evidently demonstrate that brown adipose tissue plays a significant role in whole-
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body energy homeostasis. Ucp1 knockout mice under thermo-neutral conditions exhibit 
impaired diet-induced thermogenesis and develop obesity[69], whereas brown adipose 
tissue transplantation improves glucose homeostasis and insulin sensitivity[70]. Brown 
adipose tissue clears 75% and 50% of the serum circulatory glucose and triglycerides, 
respectively[71]. In humans, retrospective 18 F-fluoro-2-deoxy-d-glucose positron 
emission tomography/computed tomography (18F-FDG-PET/CT) studies revealed brown 
adipose tissue activity was correlated with decreased incidence of insulin resistance and 
diabetes mellitus, leanness, and improved lipid profile[10, 72-74] The role of brown 
adipose tissue on energy expenditure in adult humans has been extensively investigated. 
By cold exposure, brown adipose tissue activation increases energy expenditure 10% to 
27% in brown adipose tissue-positive individuals[75-78]. Blood HbA1c, total cholesterol, 
and low density lipoprotein cholesterol levels can also be significantly lowered in brown 
adipose tissue-positive humans[79]. On the other hand, there are findings suggesting that 
clinical significance of human brown adipose tissue is still debatable. Orava et al. 
demonstrated no differences in whole body insulin-stimulated glucose disposal in the 
individuals with detectable brown adipose tissue [80]. Ouellet et al. also showed that 
plasma glucose and free fatty acid oxidation by brown adipose tissue was marginal under 
acute cold exposure though the authors verified oxidization of fatty acids by brown 
adipose tissue[81]. Nevertheless, the idea of activating brown adipose tissue as a 
therapeutic strategy still holds valid points, supported by the studies done in clinically 
applicable settings. Prolonged (5 hours) but mild cold exposure (~20 °C) enhanced 
whole-body glucose disposal, plasma glucose oxidation, and insulin sensitivity in brown 
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adipose tissue -positive (>50 ml) men[75]. Taken together, adult humans have active 
brown adipose tissue (though the amount varies in each individual), which can function 
as a promising new target for treating metabolic diseases. Future studies will refine the 
methodologies for clinical applications and pharmacological agents that stimulate brown 
adipose tissue activity, resulting in an improved metabolic profile in humans. 
 
 
Project Goals  
While intensive research in mice has developed useful insights into the regulatory 
mechanisms of thermogenic adipose tissues, the development of models to study the 
expansion and function of human adipose tissues is critically demanded in the field, 
especially due to the possible substantial differences between rodents and humans. 
Hence, this thesis aims: 1) to establish a method that enables the expansion and isolation 
of human adipose progenitor cells, 2) to test the ability of isolated adipogenic progenitors 
to form an integrated fat pad in vivo, 3) to characterize the cellular properties of adipocyte 
progenitors that in part give rise to brite/beige adipocytes, 4) to analyze the functions and 
effects of human brite/beige adipocytes on whole body metabolism in animals, and 5) to 
compare the transcriptome signatures of the progenitors and adipocytes, derived from 
classical brown (carotid perivascular), beige (outer neck subcutaneous), or white 
(abdominal subcutaneous) adipose tissue.  	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CHAPTER II: Generation of human adipocyte progenitors and formation of human 
adipose tissue in mice  
 
Author Contributions  
Jorge Lujan-Hernandez, Raziel Rojas-Rodríguez, Tiffany DeSouza, Cara Berg, Patrick 
Teebagy  
 
Summary  
This chapter is dedicated to demonstrating that human adipocyte progenitor cells 
can be generated and expanded upon pro-angiogenic stimuli in conjunction with adipose 
tissue capillary sprouting. Adipose tissue capillary-derived adipocyte progenitors can be 
differentiated into adipocytes with a conventional adipogenic cocktail including insulin, 
dexamethasone and 3-isobutyl-1-methylxanthine. Differentiated adipocytes respond to 
insulin, increase leptin secretion with insulin, and express classic adipogenic genes, 
presenting the characteristics of human primary adipocyte in vivo. In vitro differentiated 
adipocytes formed a vascularized fat pad, which successfully retained human adipocytes 
in vivo, when put into Nude mice. Progenitors that had never been differentiated in vitro 
could also form a fat pad in Nude mice though the level of human adipocyte-specific 
message detected from implants was lower than that with in vitro differentiated capillary 
cells.  These results support the interdependent growth of vessels and adipocyte 
progenitors, and further describe the methods by which we can produce human adipocyte 
progenitor cells in vitro and generate human fat pads in vivo.  
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Introduction  
 
Proliferation of human adipogenic precursors requires angiogenesis. During 
human embryonic development adipocytes first appear from emergent vascular networks 
[82], and lineage-tracing studies have demonstrated that adipocyte progenitors reside 
within the walls of adult mouse adipose tissue capillaries [83-86]. These findings suggest 
that proliferation of adipocyte and vascular progenitors may be interdependent.  
Result published over the past few years from our laboratory[49, 87-89] also 
indicate that adipogenesis occurs concomitantly with angiogenesis, and adipocyte 
progenitors can be generated using very small amounts of human adipose tissue ex vivo. 
Olga et al. reported that the sprouts formed from human adipose tissue explants consist of 
well-known blood vessel forming cells such as endothelial cells and mural cells 
(pericytes and smooth muscle cells)[89]. Furthermore, Tran et al. demonstrated classical 
endothelial capillary-forming ultra-structural features, including tight junctions, irregular 
nuclei, and pinocytic vesicles in cells comprising sprouts. In the same study, capillary 
lumens could be also observed, indicating that angiogenesis was recapitulated ex vivo in 
this system[49]. I adopted the same strategy as in Tran et al. to grow the capillary 
networks from human adipose tissue explants in order to characterize adipocyte 
progenitor cells and test their ability to form a fat pad in animals. 
The identification and development of a robust adipose stem cell population is 
attracting great attention due to the strong need for tissue replacement and regeneration in 
human patients. “Adipose-Derived Stem Cells,” or ADSC, is a heterogeneous population 
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of cells harvested from adipose tissue stromal vascular fraction (SVF), excluding 
adipocytes. ADSC or SVF has been extensively investigated as a most promising stem 
cell population and proved to contain adult stem cells that can differentiate into 
adipocytes, osteoblasts, chondrocytes and myocytes etc. Before SVF became available, 
autologous fat grafting had been frequently performed to augment soft tissues in clinical 
settings. Fat grafts, however, are restricted by varying rates of re-sorption[90] and 
complications of palpable indurations, pain, infection, abnormal breast discharge, 
lymphadenopathy and abnormalities on breast cancer screening, resulting in unreliable 
long-term outcomes after transplantation[91]. To overcome the limitations of fat grafts, 
SVF-enriched lipo-transfer is contrived where aspirated fat is combined with 
concentrated SVF of lipo-aspirate to create SVF-rich fat grafts. This approach has 
markedly improved the survival of transplanted fat as well as decreased adverse effects in 
human patients[92, 93]. The beneficial effects of these stem cells on wound healing have 
also been extensively reviewed with multiple possible mechanisms suggested, including 
secretion of pro-angiogenic factors, anti-inflammatory, anti-oxidant, and anti-apoptotic 
factors and replenishing endothelial cells, keratinocytes, fibroblasts, and smooth muscle 
cells[94, 95]. Nevertheless, the limited expandability and the significant variability in cell 
quality in terms of differentiation potential under conventional protocols necessitate the 
development of more proliferative and enriched adipogenic adult adipose stem cell 
population. In this chapter, the ability of fat pad formation in vivo was compared between 
capillary-derived adipocyte progenitors and SVF. 
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Figure 2.1. Immuno-phenotype of cells comprising the sprouts formed from human 
adipose tissue explants. 
Representative photomicrographs of newly formed cells stained for endothelial cell 
markers CD31 (A), CD34 (B), endothelial nitric oxide synthase (C), and vWF (D) are 
shown. (E) displys cells expressing α-smooth muscle actin (red) with presumably 
pericytes forming a vWF-positive capillary branch (green). Gealekman et al.,	  Depot-­‐
Specific	  Differences	  and	  Insufficient	  Subcutaneous	  Adipose	  Tissue	  Angiogenesis	  in	  
Human	  Obesity.	  Circulation, 2011.123(2): p. 186-194. 
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Figure 2.2. Angiogenic Sprouts Originating from Human Adipose Tissue. 
(C) Electron microscopy of area similar to that shown in (B), where tight junctions can be 
seen to connect cells. 
(D) Enlargement of tight junction found between two ECs. 
(F) Electron microscopy of area similar to that shown in (E), revealing lumenized 
capillaries formed by ECs joined by tight junctions. 
(G) Enlargement of area shown in (F). 
(K) Electron microscopy of lipid-laden cells revealing features of classical white 
adipocytes and of ECs, such as the tight junction in the squared area. 
(L) Enlargement of area outlined in (K). 
Khanh-Van Tran et al., The Vascular Endothelium of the Adipose Tissue Gives Rise to 
Both White and Brown Fat Cells. 2012, Cell Metabolism. 15(2), 8: p. 222-229. 
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Materials and methods  
 
General Methodology. No samples, mice or data points were excluded from the reported 
analyses. Samples were not randomized to experimental groups except where indicated. 
Analyses were not performed in a blinded fashion except where noted below.  
 
Adipose Tissue. Subcutaneous adipose tissue was obtained from panniculectomies, with 
no a-priori selection of individual donors. All specimens were collected after informed 
consent in accordance with procedures approved by the University of Massachusetts 
Institutional Review Board.  
 
Explants. Detailed methods for harvesting adipose tissue, culture of adipose tissue 
explants in Matrigel are published[96]. In brief, explants from human subcutaneous 
adipose tissue were cultured in EBM-2 media supplemented with endothelial growth 
factors (EGM-2 MV) (Lonza). In indicated experiments, Dulbecco’s Modified Eagles 
Medium (Gibco) supplemented with 10% fetal bovine serum ((DMEM-FBS) was used, 
without or with supplementation with human fibroblast growth factor-B, human 
epidermal growth factor, long R3 insulin-like growth factor 1 and vascular endothelial 
growth factor at the concentrations used in EGM2-MV, as indicated. To induce 
adipogenesis we used a minimal adipogenic cocktail of DMEM +10% FBS, 0.5 mM 3-
isobutyl-1-methylxanthine, 1 µM dexamethasone, and 1 µg/ml insulin (MDI) for 72 
hours. The medium was then replaced with DMEM plus 10% FBS. Subsequently, 50% of 
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the medium was replaced with fresh medium every other day. Adipocyte markers were 
measured by RT-PCR in RNA extracted from 3 explants per condition. Results shown in 
Figures were reproduced in explants from all panniculectomy samples studied, albeit the 
magnitude of the induction of individual markers varied. 
 
Cells. Detailed methods for harvesting adipose tissue, culture of adipose tissue explants 
in Matrigel, and harvesting of single cells from explant growth are published[96]. In 
brief, explants from human subcutaneous adipose tissue were cultured in EBM-2 media 
supplemented with endothelial growth factors (EGM-2 MV) (Lonza) for 14 days. Single 
cells suspensions from capillary growth (capillary network cells) were obtained using 
dispase[96], and plated on standard tissue culture plates. Growth and passaging of these 
cells was done using EGM-2 MV. Where indicated, adipogenic differentiation was 
induced by replacement of EGM-2 MV by DMEM +10% FBS, 0.5 mM 3-isobutyl-1-
methylxanthine, 1 µM dexamethasone, and 1 µg/ml insulin (MDI). 72 hours later, the 
differentiation medium was replaced by DMEM-FBS, which was replaced every 48 hours 
until analysis.  Adipocyte markers were measured by RT-PCR in RNA extracted from 
one well of a confluent 6 well multi-well dishes of cells. Stromal vascular fraction from 
human subcutaneous adipose tissue was isolated as described in Fitzgibbons et al [97]. In 
brief, the tissue was mechanically dissociated and treated with 2 mg/ml collagenase, 
respectively, in 20 mg/ml bovine serum albumin in phosphate-buffered saline at pH 7.4, 
37°C for 1 hour. Samples were filtered through 200, 100 and 40 µM spectra mesh 
sequentially and red blood cells were lysed. The isolated cells by centrifuging the cell 
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suspension at 400 g were grown and expanded in 10% FBS DMEM. 
 
Mice. Cells from capillary networks were grown to confluence on 150 mm dishes and 
differentiated using MDI for 10 days. Cells were detached from culture dishes by trypsin 
(0.5%)-collagenase (0.05%) digestion, suspended in Matrigel and injected 
(approximately 107 cells per mouse) into the dorsal region of 8 week-old male Nude 
mice. 7 mice were injected with 0.6 ml of differentiated capillary cells re-suspended in 
the same volume of Matrigel or 0.6 ml of DMEM with Matrigel as a control in each 
flank. Mice with differentiated capillary cells were sacrificed 24 weeks after the injection. 
Mice with non-differentiated capillary cells or stromal vascular cells were sacrificed 28 
weeks after the injection. Human implants and endogenous mouse inguinal and 
epididymal adipose tissues were collected for RNA extraction.  
 
Immunofluorescence.	  Capillary	  cells	  were	  incubated	  in	  culture	  media	  with	  500	  nM	  MitoTracker	  Red	  CMXRos	  (Invitrogen	  M7512)	  and	  1:2000	  Hoechst	  (Molecular	  Probes	  H21486)	  at	  37°C	  for	  30	  minutes.	  After	  30	  minutes,	  media	  were	  changed	  before	  visualization	  under	  the	  microscope.	  Images	  were	  taken	  with	  a	  Zeiss	  Axiovert	  100	  inverted	  microscope	  and	  AxioCam	  HRm	  camera.	  Image	  processing	  and	  quantification	  was	  performed	  using	  ImageJ	  (FIJI)	  software,	  on	  a	  file	  containing	  all	  raw	  images	  to	  be	  analyzed	  thereby	  applying	  all	  corrections	  equally	  for	  all	  comparison	  groups.	  After	  background	  subtraction,	  the	  grey-­‐scale	  image	  of	  adipocytes,	  images	  were	  converted	  into	  a	  binary	  image,	  and	  the	  size	  of	  particles	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(individual	  adipocytes)	  was	  calculated	  by	  FIJI.	  
 
ELISA. Leptin concentration in the culture medium was measured using a human leptin 
ELISA from Invitrogen (KAC2281). 100 µl of media without dilution were loaded onto 
each well of ELISA plate. 9 well per group were measured. ELISA was run according to 
the manual. 
 
RT-PCR. Adipocyte markers were measured by RT-PCR in RNA extracted from one 
well of a confluent 6 well multi-well dish of cells. Adipocyte markers were measured in 
RNA extracted from 3 explants per condition, or from one well of a confluent 6 well 
multi-well plates of cells. Probe sets used are shown in Table 1. 
 
Statistical analyses. RT-PCR results are presented as means of technical replicates with 
error range indicated. Experiments shown are representative, and have been repeated a 
minimal of 5 times with cells derived from different individuals undergoing 
panniculectomy surgery, with no a priori selection. Software employed was GraphPad 
Prism v.6. To compare groups with normally distributed values, 2-tailed unpaired Student 
t-tests were used. When normality could not be determined, the Mann-Whitney test was 
used. Data are presented as mean values ± s.e.m., or range between technical replicates 
when experiments were representative, as indicated in each figure legend. P-values are 
indicated in each case. All representative experiments have been repeated a minimum of 
5 times with tissue from different individuals, with similar results. 
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Results  
 
To determine whether human adipocyte progenitors proliferate in conjunction 
with adipose tissue capillaries we used an in vitro system in which microvessels develop 
from adipose tissue fragments in vitro. Explants from human subcutaneous adipose tissue 
from individuals undergoing panniculectomy surgery were embedded in Matrigel and 
cultured in DMEM (Dulbecco’s Modified Eagle’s Medium) + 10% FBS (Fetal Bovine 
Serum), or in EGM2-MV (Endothelial Cell Growth Medium-Microvascular) in the 
absence or presence of pro-angiogenic growth factors VEGF (vascular endothelial growth 
factor), hFGF-B (human fibroblast growth factor B), hEGF (human epidermal growth 
factor), R3-IGF-1 (long R3 insulin-like growth factor 1) (Fig 1a), and imaged after 10 
days in culture.  
Capillary growth was negligible in explants cultured in either DMEM of EGM-2 
MV in the absence of growth factors, but clearly measurable in DMEM or EGM-2 MV in 
their presence (Figure 2.3). Maximal growth was seen in EGM2-MV, consistent with the 
optimized pro-angiogenic properties of this medium. Over time cells at the tips of the 
sprouts projected thin filopodia into the gel, divided, and aligned to form thicker branches 
(Figure 2.4), which previously have been seen to include endothelial and non-endothelial 
cells[98, 99]. To determine whether any of these cells correspond to adipocyte 
progenitors, we exposed cultures to adipogenic conditions. Because activation of 
peroxisome-proliferator activated receptor gamma (PPARγ) by ligands such as 
thiazolidenediones can induce lipid accumulation in cells independently of adipogenic 
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conversion[100], we used a minimal adipogenic cocktail of 3-isobutyl-1-methylxanthine, 
dexamethasone and insulin (MDI). After approximately 6 days, we observed a loss of 
continuity between cells forming the capillary structure, and lipid droplets in cells within 
the capillaries (Figure 2.4). These morphological changes were accompanied by 
induction of classical adipocyte markers (Figure 2.5). These results were reproduced in 
explants from all panniculectomy samples studied (Table 2), albeit the magnitude of the 
induction of individual markers varied. Thus, proliferation of human adipocyte 
progenitors occurred in conjunction with capillary growth, and is critically dependent on 
pro-angiogenic growth factors. 
 Expanded and differentiated capillary cells, as embedded in Matrigel, were 
subjected to the human recombinant insulin (1 µM in culture) to address the question 
whether these capillary-derived human adipocytes behave in vitro as they do in vivo. 
After embedding of human adipose tissue explants, I grew the cells in EGM-2 MV for 18 
days and induce adipocyte differentiation with MDI cocktail in 10% FBS DMEM for 14 
days. Fresh insulin was added to the medium every the other day for 14 weeks. Picture of 
adipocytes were taken and smaller volume of fresh medium with insulin was introduced 
to detect human adiponectin secreted into the media. The fresh media was incubated for 3 
days without media change and collected for human leptin ELISA. Compared to 
capillary-derived adipocytes appeared in Figure 2.3., adipocytes stimulated by insulin 
accumulated more lipid droplets and significantly enlarged their cell body. Also, as they 
grow larger adipocytes changed their distribution of lipid droplets from small multi-
locular into large uni-locular. Adipocytes survived for at least 14 weeks in vitro culture 
	   22	  
with insulin and still retained healthy mitochondria, confirmed by mitochondrial staining 
with 500	  nM	  MitoTracker	  Red	  CMXRos	  and	  1:2000	  Hoechst.	  Human	  leptin	  ELISA	  detected	  human	  leptin	  from	  cultured	  media	  from	  these	  adipocytes.	  With	  insulin,	  leptin	  secretion	  was	  approximately	  3-­‐folds	  increased	  when	  9	  wells	  were	  tested	  in	  each	  group.	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Figure 2.3. Quantification of capillary growth. 
Top: Explant growth in DMEM (top), DMEM + angiogenic growth factors (middle) or 
EGM-2 MV + angiogenic growth factors (bottom). Scale bars are 1 cm (left panels) and 
200 µm (right panels).  
Bottom Graph: Growth area (arbitrary units) from explants grown for 11 days in the 
absence (– GF) or presence (+ GF) of angiogenic growth factors. Plotted are means and 
s.e.m., from 6 explants per condition from 2 different individuals (n = 12). Statistical 
significance was calculated using the Mann Whitney test * P < 0.05 ** P < 0.05. 
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Figure 2.4. High-resolution representative images of explants grown for 5 (left), 12 
(middle) or 18 (right) days, exposed to MDI at day 12. Arrowheads indicate elongated 
cells forming the sprouts, and arrows indicate lipid droplets. Scale bars are 200 µm and 
50 µm (insert). 
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Figure 2.5. Biochemical characteristics of capillary-derived adipocytes. 
Top: Left figure shows embedded human adipose explant in Matrigel with few sprouting 
capillary cells. Middle panel displays more capillary growth with EGM-2 MV. 
Adipocytes stimulated with human insulin in the left panel appear to be larger than those 
without insulin presented in Figure 2.4. 
Bottom Left: Enlargement of adipocytes over time up to 14 weeks with insulin in 
culture. Cells stained with MitoTracker Red CMXRos (500 nM) and Hoechst (1:2000). 
Bottom middle: Quantified adipocyte size by analyzing the pictures of adipocytes.  
Bottom Right: Human leptin ELSA with 9 replicate wells.  
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To determine whether proliferation and/or differentiation of adipocyte progenitors 
required intercellular interactions within the capillary, or on interactions with Matrigel 
components, we generated single cell suspensions from the micro-vessels, passaged them 
once on standard tissue culture dishes and subjected them to differentiation. Numerous 
cells differentiated into adipocytes, identifiable by lipid droplets that increased in size and 
coalesced over time (Figure 2.6), and by the induction of adipocyte genes (Figure 2.7). 
Results shown were similar in capillary network cells from all explants studied, albeit the 
magnitude of the induction of individual genes varied.  
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Figure 2.6. Morphology of capillary-derived adipocytes. 
A representative field of capillary network cells at days 0 (top left), 6 (top right), 12 
(bottom left) and 18 (bottom right) after induction of differentiation; arrows indicate 
growth of lipid droplets within a single adipocyte. Scale bars are 50 µm. 
 
 
 
Figure 2.7. RT-PCR for adipogenic genes 
in non-differentiated (– MDI) or 
differentiated (+ MDI) cells seven days after 
induction of differentiation. RT-PCR results 
are expressed as the fold over the minimum 
detectable value in the series, and represent 
the means and range of 2 technical 
replicates, of representative experiments that 
have been replicated a minimum of three 
times with cells from separate individuals. 
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Next we tested whether these adipocytes from capillary networks can form a fat 
pad in vivo. The ability of forming a fat pad was compared among three cell types: 
capillary cells after differentiation (ASC-diff; adipose subcutaneous capillary cells-
differentiated), capillary cells without differentiation (ASC) and stromal vascular fraction 
without differentiation (SVF). SVF or adipose-derived stromal cells is an entire cell 
population except for adipocytes harvested from adipose tissue. It is heterogeneous, yet 
has been studied in numerous studies as adipocyte progenitors[101]. Thus, the 
comparison between ASC and SVF could be useful to better understand the 
characteristics of adipocytes progenitors. All three populations were expanded in EGM-2 
MV and maintained in 10% FBS DMEM with or without MDI. Then each was prepared 
for injection in a suspension with Matrigel as described in the Materials and Methods 
section. 28 weeks after the injection, mice injected with non-differentiated ASC or SVF 
were sacrificed. Mice with diff-ASC were sacrificed 28 weeks post injection. When put 
into Nude mice, all three cell-types formed a vascularized fat pad in vivo (Figure 2.8). 
However, RT-PCR results (Figure 2.9) showed the level of adiposity and vascularization 
of the fat pad varied in each condition. ASC-diff contained the highest amount of human 
adipocytes, followed by ASC and SVF. On the other hand, formation of human vascular 
endothelial tight junctions, assessed by CDH5, was highest in SVF and lowest in ASC-
diff. We could also detect the infiltration of mouse adipocytes and vascular endothelial 
cells into the structure. To conclude, ASC retain their entity as adipocytes in vivo once 
they differentiation in vitro and can also can differentiate into adipocytes in vivo even 
when they are put into mice as preadipocytes. SVF preadipocytes are able to differentiate 
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into adipocyte in vivo as well but at a much lower level of differentiation compared to 
ASC. 
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Figure 2.8. Morphology of the implants. 
 
  
 
 
Formed fat pad in a mouse injected with ASC-diff. The implant was 
harvested 24 weeks after the injection.  
 
 
 
                               
 
 
 
Formed fat pad in a mouse injected with ASC without in 
vitro differentiation. The implant was harvested 28 weeks 
after the injection.  
 
 
 
 
 
Formed fat pad in a mouse injected with 
SVF without in vitro differentiation. The 
implant was harvested 28 weeks after the 
injection.  
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Figure 2.9. RT-PCR on formed fat pads. ASC-diff (n=4), ASC (n=7) and SVF (n=4). 
Technical triplicates. Human or mouse primers were designed to specifically detect 
human or mouse exclusively. PLIN1: perilipin1, CDH5: V-Cadherin. Values were plotted 
relative to the ASC-diff PLIN1. 
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Table 1. Human or mouse-specific probes used for RT-PCR 
 
Gene name                                         Forward (Fw) or Reverse (Rv) probe Sequences 
Human-specific CDH5 Fw  CTGCTGCAGGGTCTTTTTCT 
Human-specific CDH5 Rv   AGGGCATGATGGTCAGTCTC 
Mouse-specific CDH5 Fw  TACTCAGCCCTGCTCTGGTT 
Mouse-specific CDH5 Rv   TGGCTCTGTGGTGCAGTTAC 
Human-specific Perilipin1 Fw ACCAGCAAGCCCAGAAGTC 
Human-specific Perilipin1 Rv            CATGGTCTGCACGGTGTATC 
Mouse-specific Perilipin1 Fw  CTGTGTGCAATGCCTATGAGA 
Mouse-specific Perilipin1 Rv             CTGGAGGGTATTGAAGAGCCG 
Human RPL4 Fw   TGTTTGCACCAACCAAAACCT 
Human RPL4 Rv   GCAGAACAGATGGCGTATCGT 
Mouse RPL4 Fw             CCCCTCATATCGGTGTACTCC 
Mouse RPL4 Rv             ACGGCATAGGGCTGTCTGT 
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Discussion  
 
In this chapter, the results showed that human adipocyte progenitor cells could be 
generated and expanded upon pro-angiogenic stimuli in adipose tissue capillary 
networks. Differentiated adipocyte progenitors responded to insulin, increased leptin 
secretion with insulin treatment, and expressed canonical adipogenic genes. These cells 
recapitulated the characteristics of human primary adipocyte in vitro and also in vivo. In 
vitro differentiated adipocyte progenitors formed a vascularized fat pad when put into 
Nude mice, which successfully maintained live human adipocytes with adipogenic gene 
expression signatures in vivo.  
Comparison between adipose subcutaneous capillary cells (ASC) and adipose 
stromal vascular fraction (SVF) suggested that ASC better enriched adipocyte progenitors 
or the quality (viability, differentiation potential) of cells was superior in ASC. When 
injected with the same number of cells into Nude mice, ASC showed a higher level of 
human-specific adipocyte gene expression in the formed fat pad than SVF did. 
Considering the significant interests and frequent usage of SVF in the clinical fields, the 
discoveries from this thesis regarding improved harvesting and expanding methods for 
adult adipose stem cells could have a great impact on clinical applications. Given the fact 
that adipocyte progenitors were highly enriched in capillary associated cells, 
understanding the characteristics (markers, responsiveness to certain growth factors, 
differentiation potential into multiple cell types) of the ASC population will bolster the 
advancement of basic research on mechanism of adult stem cell expansion and 
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differentiation. Further investigation into cellular attributes of ASC at the clonal level is 
described in the following CHAPTER V: Concluding remarks and future directions. 	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CHAPTER III: Human ‘brite/ beige’ adipocytes develop from capillary networks 
and their implantation improves metabolic homeostasis in mice 
 
Author Contributions  
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Hye-Lim Noh, Jason K. Kim, Marcus P. Cooper, Timothy Fitzgibbons, Michael A. 
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Summary  
The results in this chapter reveal that human adipocyte progenitor cells proliferate 
in response to pro-angiogenic stimuli in conjunction with adipose tissue angiogenesis, 
and display the cardinal feature of ‘brite/beige’ adipocytes. Brite/ beige adipocytes have 
the near absence of thermogenic gene expression under basal conditions, but their 
transcriptome profile changes remarkably in response to adrenergic stimulation, inducing 
a wide range of thermogenic genes. To our knowledge, these findings are the first to 
show the growth and differentiation of human ‘brite/beige’ cells, and the assessment of 
their effects of systemic glucose homeostasis. These cells differ from human brown 
adipocyte cell lines established through immortalization of human precursors [102, 103] 
or differentiation of human pluripotent stem cells[104] in their highly inducible 
expression of a thermogenic phenotype, in the development of uncoupled respiration, and 
in their capacity to affect metabolism upon transplantation in vivo. Unexpectedly, global 
gene expression analyses reveal that activation of human brite/beige adipocytes induces a 
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neuroendocrine phenotype including expression of interleukin-33, known to regulate 
glucose homeostasis in mice, and the proprotein convertase PCSK1, which is genetically 
associated with human obesity. The findings demonstrated in this chapter suggest a direct 
effect of human beige/brite adipocytes to improve glucose homeostasis, and reveal 
neuroendocrine properties that might contribute to these beneficial metabolic actions. 
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Introduction  
 
Due to the energy wasting property of brown fat, researchers have been trying to 
answer these questions: 1) Do humans have thermogenic brown or inducible beige 
adipose tissue? 2) If so, do these thermogenic fat depots affect systemic metabolism? 3) 
If they are beneficial, how can we activate these depots? 
For the first question, the use of 18F-fluoro-2-deoxy-d-glucose positron emission 
tomography computed tomography (18F-FDG-PET) imaging has made it evident that 
humans also have substantial amount of adipose depots with UCP1-positive adipocytes, 
and these tissues can take up glucose by cold or b-adrenergic agonist stimulation[77, 105-
109].  
Various selective markers for brown and beige adipocytes have been identified in 
mice and humans, although in human there are discrepancies among the literature 
primarily due to the high heterogeneity within human thermogenic fat depots. Unlike 
human infants with interscapular brown adipose tissue that resembles rodent brown 
fat[77], adult humans have the most enriched with uncoupling protein1 (UCP1)-positive 
adipocytes in the supraclavicular region with both bona fid brown (UCP1, ZIC1 and 
LHX8)[110] and beige (Tbx1, Cd137, Tmem26, Cited1) adipocytes, depending on the 
depth in the neck [110-112].  
Hence, to clarify these complex findings, Xue et al.[113] and Shinoda et al.[114] 
have recently isolated and immortalized clonal UCP1-positive adipocytes from adult 
human neck brown adipose tissue. Genome-wide analyses based on microarray indicated 
	   38	  
that the cloned human brown adipocytes possess molecular signatures that resemble 
murine beige adipocytes, rather than classical brown adipocytes[114]. This evidence 
suggests that adult human neck brown fat is mainly, if not all, composed of recruit-able 
beige adipocytes. This view is supported by other works on chronic cold acclimation–
recruited brown fat in the supraclavicular region of adult humans, which did not present 
detectable brown fat activity before activation[76, 115, 116]. 
Excitingly, the presence of inducible brown adipose tissue is associated with an 
increase in cold-induced energy expenditure[76, 78, 81, 109, 115] and an improvement in 
postprandial insulin sensitivity[116].  
The last question whether we can activate these thermogenic depots can be in part 
answered by the complete summary by Shingo et al. of recently discovered molecular 
mechanisms of environmental cues that induce beige adipocyte biogenesis[117]. The list 
includes cold exposure, exercise, bariatric surgery, cachexia, BDNF, innate immunity 
(IL-33, IL4, BMP4, BMP7, BMP8b), endocrine hormones (FGF21, GDF5, natriuretic 
peptides, VEGF, PPARγ agonists, FXR agonist) and compounds (notch inhibitor, GLP1 
agonist, TBK1 and IKK-e inhibitor, guanylyl cyclase, TGFβ antagonists).   
A profound number of studies have contributed to our understating of human 
brown and beige adipocytes, by which we can answer those three key questions. 
However, we still have limited knowledge on cellular identities of UCP1-positive 
adipocytes in other adipose depots such as in the subcutaneous white adipose depots. In 
this chapter, our study validated the presence of beige adipocyte progenitors in human 
subcutaneous adipose tissue, adipocytes from which induced UCP1 expression upon 
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adrenergic stimuli, displayed uncoupled respiration, and finally exhibited metabolic 
benefits in mice. 
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Materials and methods  
 
General Methodology. No samples, mice or data points were excluded from the reported 
analyses. Samples were not randomized to experimental groups except where indicated. 
Analyses were not performed in a blinded fashion except where noted below.  
 
Materials. Matrigel from BD biosciences (56231); EGM-2 MV from Lonza; Anti-human 
UCP1 antibody from Abcam (ab10983); anti Heat Shock Protein 70 from ThermoFisher 
Scientific (MA3-028); anti human IL-33 from ThermoFisher Scientific (PA5-20397); 
Adiponectin human-specific ELISA kits from Invitrogen (KHP0041); Forskolin and 
Isoproterenol hydrochloride from Sigma (F3917 and I6504, respectively). iButtons were 
purchased from Embedded Data Systems (DS1922L-F5#). 
 
Adipose Tissue. Subcutaneous adipose tissue was obtained from panniculectomies, and 
peri-carotid adipose tissue from elective vascular surgeries with no a-priori selection of 
individual donors. All specimens were collected after informed consent in accordance 
with procedures approved by the University of Massachusetts Institutional Review 
Board. The characteristics of patients from which tissues were used for indicated 
experiments are described (Table 2). 
 
Explants. Detailed methods for harvesting adipose tissue, culture of adipose tissue 
explants in Matrigel are published[96]. In brief, explants from human subcutaneous 
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adipose tissue were cultured in EBM-2 media supplemented with endothelial growth 
factors (EGM-2 MV) (Lonza). In indicated experiments, Dulbecco’s Modified Eagles 
Medium (Gibco) supplemented with 10% fetal bovine serum (DMEM-FBS) was used, 
without or with supplementation with VEGF (vascular endothelial growth factor), hFGF-
B (human fibroblast growth factor B), hEGF (human epidermal growth factor), R3-IGF-1 
(long R3 insulin-like growth factor 1) at the concentrations used in EGM2-MV, as 
indicated. To induce adipogenesis we used a minimal adipogenic cocktail of DMEM 
+10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 1 µM dexamethasone, and 1 µg/ml 
insulin (MDI) for 72 hours. The medium was then replaced with DMEM plus 10% FBS. 
Subsequently, 50% of the medium was replaced with fresh medium every other day. 
Adipocyte markers were measured by RT-PCR in RNA extracted from 3 explants per 
condition. Results shown in Figures were reproduced in explants from all panniculectomy 
samples studied (Table 2), albeit the magnitude of the induction of individual markers 
varied. 
 
Cells. Detailed methods for harvesting adipose tissue, culture of adipose tissue explants 
in Matrigel, and harvesting of single cells from explant growth are published[96]. In 
brief, explants from human subcutaneous adipose tissue were cultured in EBM-2 media 
supplemented with endothelial growth factors (EGM-2 MV) (Lonza) for 14 days. Single 
cells suspensions from capillary growth (capillary network cells) were obtained using 
dispase[96], and plated on standard tissue culture plates. Growth and passaging of these 
cells was done using EGM-2 MV. Where indicated, adipogenic differentiation was 
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induced by replacement of EGM-2 MV by DMEM +10% FBS, 0.5 mM 3-isobutyl-1-
methylxanthine, 1 µM dexamethasone, and 1 µg/ml insulin (MDI). 72 hours later, the 
differentiation medium was replaced by DMEM-FBS, which was replaced every 48 hours 
until analysis. In experiments to investigate the effects of ‘brite/beige’ adipocytes in vivo, 
cells from capillary networks were grown to confluence into 150 mm dishes, 
differentiated using MDI for 10 days, and browning induced for 7 days with forskolin. 
Cells were then were recovered from culture dishes by trypsin-collagenase digestion, 
suspended in Matrigel and injected (approximately 107 cells per mouse) into the dorsal 
region of male NOD-scid IL2rgnull (NSG) mice[118]. 
 
ELISA. Adiponectin concentration in the culture medium was measured using a human-
specific adiponectin ELISA from Invitrogen (KHP0041). For analysis of thermogenic 
gene expression, isoproterenol and forskolin were used at final concentrations of 10 and 
50 µM, unless otherwise indicated in the figures. 
 
RT-PCR. Adipocyte markers were measured by RT-PCR in RNA extracted from one 
well of a confluent 6 well multi-well dish of cells. Adipocyte markers were measured in 
RNA extracted from 3 explants per condition, or from one well of a confluent 6 well 
multiwell dish of cells. Probe sets used are shown in Table 3. 
Immunofluorescence. Cells were fixed in 4% formaldehyde, stained, mounted and 
imaged with a Zeiss Axiovert 100 inverted microscope and AxioCam HRm camera. 
Image processing and quantification was performed using ImageJ (FIJI) software, on a 
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file containing all raw images to be analyzed thereby applying all corrections equally for 
all comparison groups. After background subtraction the greyscale image is converted 
into a binary image, and the sum of white pixels in each individual image is recorded. 
 
Oxygen consumption. Oxygen consumption and mitochondrial parameters in intact cells 
were obtained using the XF24 Extracellular Flux Analyzer equipped with a FluxPak mini 
kit (#100867-100) from Seahorse Biosciences. In this system, oxygen consumption rates 
are calculated from 4 independent measurements obtained at 5 min intervals at baseline 
and after addition of specific drugs. For each experiment, the means from 3 replicate 
wells were recorded. For assessment of mitochondrial parameters, the values for the 4 
independent measurements recorded for each condition were averaged, and parameters 
calculated as follows: ATP-linked respiration = basal OCR - oligomycin OCR; Proton 
leak = oligomycin OCR - rotenone+antimycin OCR; maximal capacity= FCCP OCR; 
reserve capacity = FCCP OCR – basal OCR; non-mitochondrial respiration = rotenone + 
antimycin OCR. Values presented are the means and s.e.m. of 4 independent 
experiments. For assessment of GDP sensitivity, cells were detached using 
trypsin/collagenase and suspended in respiration buffer[119], permeabilized with 
20 µg/ml digitonin in respiration buffer for 5 minutes, washed again and oxygen 
consumption measured at 1 sec intervals using a Clark-type Oxygraph Plus recorder 
(Hansatech Instruments). Oxygen consumption rates were expressed as the slopes of the 
linear regression fits for each trace, derived from a minimum of 300 points, after each 
addition. GDP was used at a final concentration of 1 mM.  
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Affymetrix arrays. Total RNA was isolated using TRIzol. Affymetrix protocols were 
followed for the preparation of cRNA, which was hybridized to HTA-2.0 arrays. Raw 
expression data collected from an Affymetrix HP GeneArrayScanner was normalized 
across all data sets using the RMA algorithm as implemented by the Affymetrix 
Expression Console. Expression analysis was performed using the Affymetrix 
Transcriptome Analysis Console v.3.0. The data discussed in this publication have been 
deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series 
accession number GSE73385. 
 
Mice. All animal use was in accordance with the guidelines of the Animal Care and Use 
Committee of the University of Massachusetts Medical School. For all experiments 
reported male NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NOD-scid IL2rγnull, NSG) 
mice[118] were used, at 12-14 weeks of age. Mice were obtained from the Jackson 
Laboratory.  
In experiments to investigate the effects of ‘brite/beige’ adipocytes in vivo, cells from 
capillary networks were grown to confluence into 150 mm dishes, differentiated using 
MDI for 10 days, and browning induced for 7 days with forskolin. Cells were then were 
recovered from culture dishes by trypsin-collagenase digestion, suspended in Matrigel 
and injected (approximately 107 cells per mouse) into the dorsal region of male NOD-
scid IL2rgnull (NSG) mice[118]. 
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Mice were injected subcutaneously with Matrigel or cells suspended in Matrigel 
After the times indicated, animals were sacrificed and tissues were removed for further 
study. Where indicated, mice were fed with a 60% high fat diet (Research Diets, Inc. 
D12492). Glucose tolerance curves were performed with 2g/Kg glucose after 8 or16h 
fasting, as indicated. The sample size chosen for glucose tolerance tests, temperature 
recordings and hyperinsulinemic-euglucemic clamp studies were based on preliminary 
data in control mice to determine variance for each parameter. Male animals of similar 
age bred under the same conditions were randomly assigned to Matrigel or cells, or to 
non-stimulated or forskolin-stimulated cells, and the investigator conducting the glucose 
tolerance tests, hyperinsulinemic-euglycemic clamps, and serum adiponectin 
measurements was blinded to the group (matrigel or cells, normal diet or high fat diet) 
allocation. 
 
Hyperinsulinemic-euglycemic clamp. Survival surgery was performed at 5~6 days 
before clamp experiments to establish an indwelling catheter in the jugular vein. On the 
day of the clamp experiment, mice were fasted overnight (~15 hours), and a 2-hour 
hyperinsulinemic-euglycemic clamp was conducted in conscious mice with a primed and 
continuous infusion of human insulin (150 mU/kg body weight priming followed by 2.5 
mU/kg/min; Humulin, Eli Lilly & Company, Indianapolis, IN, USA). To maintain 
euglycemia, 20% glucose was infused at variable rates during clamps. Whole body 
glucose turnover was assessed with a continuous infusion of [3-3H] glucose 
(PerkinElmer, Waltham, MA, USA), and 2-7deoxy-D-[1-14C]glucose (2-[14C]DG) was 
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administered as a bolus (10 µCi) at 75 minutes after the start of clamps to measure 
insulin-stimulated glucose uptake in individual organs.  
 
Statistical analyses. RT-PCR results are presented as means of technical replicates with 
error range indicated. Experiments shown are representative, and have been repeated a 
minimal of 5 times with cells derived from different individuals undergoing 
panniculectomy surgery, with no a priori selection. The number of animal chosen for 
glucose tolerance tests, temperature recordings and hyperisnulinemic-euglucemic clamp 
studies were based on preliminary data in normal control mice to determine variance for 
each parameter. Software employed was GraphPad Prism v.6. To compare groups with 
normally distributed values, 2-tailed unpaired Student t-tests were used. When normality 
could not be determined, the Mann-Whitney test was used. Data are presented as mean 
values ± s.e.m. or range between technical replicates when experiments were 
representative, as indicated in each figure legend. P-values are indicated in each case. All 
representative experiments have been repeated a minimum of 5 times with tissue from 
different individuals, with similar results. 
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Results  
 
To determine whether cells generated from capillary networks include 
‘brite/beige’ adipocytes, we stimulated cultures acutely and chronically with the 
adenylate cyclase activator forskolin, and analyzed thermogenic gene expression by RT-
PCR (Figure 3.1). UCP1 mRNA was almost undetectable before and after adipogenic 
differentiation, but was induced rapidly in response to forskolin, and remained elevated in 
response to chronic exposure to the drug, as were canonical brown fat cell genes CIDEA 
(cell death inducing DFFA-like effector a) and DIO2 (deiodinase 2) (Figure 3.1). We also 
detected genes previously identified in mouse adipocyte progenitors, including CD29 
(integrin beta 1), CD24 (cluster of differentiation 24), PDGFRA (platelet-derived growth 
factor receptor alpha) and ZNF423 (zinc finger protein 423), or enriched in ‘brite/beige’ 
adipocytes and human and mouse adipose tissue[120] (Fig. 3.2). To determine whether 
cells responded to physiological stimuli that cause “browning” in vivo, we compared the 
responses of non-differentiated and differentiated cells to forskolin and isoproterenol 
(Fig. 3.3). No induction was seen in non-differentiated cells, but differentiated adipocytes 
responded to both stimuli (Fig. 3.3). Notably, the human-selective β3 adrenergic agonist 
Mirabegron, which activates human supraclavicular fat[121], was more potent than the 
murine-selective β3 agonist CL316,243 in inducing UCP1 expression in differentiated 
cells (Fig. 3.3), consistent with the presence of functional β3 adrenergic receptors in these 
human adipocytes.  
 
	   48	  
 
Figure 3.1. RT-PCR of thermogenic genes. Experimental scheme (top) and RT-PCR of 
indicated genes (bottom), expressed as the fold over the minimum detectable value in the 
series. Shown are means and range of 2 technical replicates. These results have been 
replicated with cells from 3 separate individuals.  
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Figure 3.2. Expression	  of	  pre-­‐adipocyte	  and	  beige/brown	  adipocyte	  markers	  in	  cells	  from	  human	  capillary	  networks.	  a)	  Mean	  probe	  intensity	  values	  obtained	  in	  HTA-­‐2.0	  Affymetrix	  arrays	  for	  the	  genes	  indicated	  on	  the	  x-­‐axis,	  for	  cells	  without	  exposure	  to	  differentiation	  cocktail	  (Control),	  exposed	  to	  MDI	  for	  3	  days	  and	  cultured	  for	  an	  additional	  11	  days	  (MDI),	  or	  treated	  as	  in	  MDI	  but	  exposed	  to	  forskolin	  for	  7	  days	  prior	  to	  RNA	  extraction	  (FSK).	  b)	  RT-­‐PCR	  analysis	  for	  genes	  indicated	  in	  the	  x-­‐axis,	  for	  cells	  prepared	  as	  described	  in	  (a),	  compared	  to	  samples	  from	  peri-­‐carotid	  fat	  obtained	  from	  4	  individuals.	   Values	  are	  expressed	  as	  the	  fold	  over	  the	  lowest	  detected	  value	  in	  the	  set	  for	  each	  gene.	  Values	  for	  C,	  MDI	  and	  FSK	  represent	  the	  mean	  and	  SEM	  from	  cells	  derived	  from	  three	  individuals. 
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Figure 3.3. UCP1 mRNA expression. Experimental scheme (top) and UCP1 mRNA 
expression (bottom left) in cells exposed to isoproterenol or forskolin as indicated in the 
scheme, or in response to different concentrations of adrenergic agonists (bottom right). 
Plotted are means and s.e.m. of 3 biological replicates (n = 3); statistical difference 
relative to CL316,243 was determined at each concentration using Student t-tests 
corrected for multiple comparisons using the Holm-Sidak method  * P < 0.05, ** P < 
0.01, **** P < 0.0001. 
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The increase in UCP1 mRNA levels translated into an increase in protein as 
UCP1 was detected by immunofluorescence in most adipocytes, and progressively 
increased in abundance upon chronic exposure to forskolin (Figure 3.4). Mitochondria 
containing UCP1 were rounded, dense and abundant (Figure 3.5), a feature reminiscent 
of brown adipose tissue mitochondria[122]. In contrast, interspersed cells containing no 
detectable UCP1 contained the linear, sparse mitochondria (Figure 3.5). 
 
 
 
 
Figure 3.4. UCP1-protein expression. Differentiated 
cells exposed to forskolin for 0 (left panel), 3 (middle 
panel) and 7 (right panel) days showing UCP1 (green), 
lipid droplets (red), and nuclei (blue). Scale bars are 
200 µm. Plotted are means and s.e.m. of UCP1 
staining intensity from 2 fields per coverslip, of cells 
from 3 different individuals (n = 6). Statistical 
significance was assessed using the Mann-Whitney 
test versus non-differentiated cells, ** P < 0.01 *** P 
< 0.001.  
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Figure 3.5. Immunofluorescence-staining for mitochondria. Mitochondrial Hsp70 
(left panel) and UCP1 (right panel) in adipocytes exposed to forskolin for 1 week. 
Arrowheads indicate linear mitochondrial structures in cell devoid of UCP1. Arrows 
indicate rounded mitochondrial structures containing both UCP1 and Hsp70. Scale bars 
are 20 µm. 
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UCP1 was functionally significant, as cells treated chronically with forskolin 
displayed enhanced basal and uncoupled oxygen consumption (Figure 3.6), and 
mitochondrial parameters following addition of specific inhibitors (Figure 3.6) revealed 
decreased ATP-linked oxygen consumption and enhanced proton leak. The enhanced 
proton leak was at least in part attributable to the presence of UCP1, as respiratory rate 
was inhibited in response to 1 mM GDP in digitonin-permeabilized cells (Figure 3.7).  
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Figure 3.6. Oxygen consumption rate by Seahorse. 
Left: Oxygen consumption by adipocytes exposed to vehicle or forskolin for 7 days. 
Plotted are the means and s.e.m. of 4 experiments assayed in triplicate (n = 4).   
Right: Summary data for oxygen consumption parameters, calculated as described in 
online methods, derived from the means and s.e.m. of cells from 4 separate individuals 
assayed in triplicate (n = 4).  Statistical significance was assessed using 2-tailed unpaired 
Student t-tests, * P < 0.05, ** P < 0.005.  
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Figure 3.7. Oxygen consumption rate with digitonin. 
Oxygen consumption rate in digitonin-permeabilized adipocytes exposed to vehicle or 
forskolin for 7 days. Plotted are the means and s.e.m. of four experiments (n=4). 
Statistical significance assessed using 2-tailed unpaired Student t-tests, *P < 0.05. 
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Other changes consistent with known properties of thermogenic adipocytes were 
also seen, including the remodeling of large lipid droplets into numerous small lipid 
droplets (Figure 3.8)[123, 124], accompanied by a large increase in expression of PLIN1 
(perilipin-1) (Figure 3.9), consistent with an increase in droplet surface. Increased 
expression of FABP4 (fatty acid binding protein 4) and SLC2A4 (Glut 4), involved in 
uptake of lipids and glucose, and changes in expression of LEP (leptin) (decreased) and 
ADIPOQ (adiponectin) (increased) were observed (Figure 3.9), a pattern consistent with 
circulating concentrations of these adipokines in mice treated with ‘pro-browning’ β3 
adrenergic agonists[125]. Thus, adipocytes derived from human capillary networks 
possess the cardinal biochemical and physiological characteristics of ‘brite/beige’ cells. 
 
 
 
Figure 3.8. Lipid droplets (green), mitochondria (red) and nuclei (blue) in 
adipocytes without (left) or with (right) exposure to forskolin for 14 days. Scale bars are 
20 µm.  
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Figure 3.9. RT-PCR of PLIN1, FABP4, SLC2A4, LEP and ADIPOQ, expressed as 
the fold relative to t = 0. Shown are means and range of 2 technical replicates. These 
results have been replicated a minimum of 3 times with cells from separate individuals. 
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To determine the similarity of ‘brite/beige’ adipocytes generated from capillary 
networks to human thermogenic fat we obtained peri-carotid adipose tissue from four 
individuals undergoing elective carotid endarterectomy (Table 2). Relative to the 
expression of ADIPOQ, significant variability in UCP1 and DIO2 levels amongst 
samples of peri-carotid fat was observed (Figure 3.10), but higher values were 
comparable to those seen in ‘brite/beige’ adipocytes from capillary networks. Thus, these 
adipocytes resemble thermogenic adipose tissue in humans. 
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Table 2. Patient Characteristics (Panniculectomy) 
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Figure 3.10. RT-PCR for UCP1, ADIPOQ and DIO2 in non-differentiated (C), 
differentiated (MDI), and forskolin-treated adipocytes (FSK), and perivascular adipose 
tissue (PV). Values represent fold difference over the lowest detectable value in the series 
for the respective probe set. Plotted are means and s.e.m. from 2 technical replicates of 
samples from 3 (cells) or  4 (PV) individuals. 
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We next asked whether human ‘brite/beige’ cells could be functional in vivo. 
Cells were grown, differentiated, and stimulated with forskolin as described in Online 
Methods. We routinely obtained cultures with unilocular and multilocular adipocytes, 
collected them by trypsinization, resuspended them in Matrigel and implanted them into 
the dorsal region of NOD-scid IL2rgnull (NSG) mice (Figure 3.11). After up to 11 weeks 
following implantation we observed only solidified remains of the gel in the dorsal region 
under the skin of mice receiving only Matrigel (Figure 3.11). In contrast, we observed 
well-delineated vascularized adipose tissue structures in mice implanted with cell 
suspensions (Figure 3.11). These structures were clearly demarcated from surrounding 
tissue and contained large patches of adipocytes and vasculature (Figure 3.12). Human 
adipocytes were viable and integrated into the mouse circulation, as we detected human 
adiponectin in serum from mice harboring implanted cells, but not in mice receiving 
Matrigel only (Figure 3.13). 
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Figure 3.11.  Phase image of cells for implantation (top left, scale bar is 100 µm); 
suspension of cells (bottom left); dorsal area of mouse injected with Matrigel alone (top 
middle, scale bar is 1 cm); collected remnants of the hydrogel (top right, scale bar is 1 
cm); dorsal area of mouse injected with cells (bottom middle, scale bar is 1 cm); excised 
adipose structure (bottom right, scale bar is 1 cm) displaying vascularization (arrows).  
 
 
 
 
 
 
 
  
	   64	  
 
 
Figure 3.12. Representative H&E staining of implant; dotted red line separating 
implant from surrounding mouse adipose tissue, blood vessels within the implant (arrow). 
Scale bars are 300 µm and 75 µm (enlargement). Similar results were seen in 8 additional 
implants.  
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Figure 3.13. Human adiponectin in mice sera from 6 mice implanted with either 
Matrigel alone or with cells, in serum from a control C57BL6 mouse, and in a 1:500 
dilution of normal human serum. 
 
 
 
 
 
 
 
 
 
	   66	  
Remarkably, implanted adipocytes maintained the ‘brite/beige’ phenotype, as we 
detected human-specific UCP1 and PLIN1 expression in the adipose tissue structure at 
levels comparable to those found in cells prior to implantation (Figure 3.14), and we 
observed multi-locular adipocytes in the excised structure (Figure 3.15).  
 
 
 
 
Figure 3.14. RT-PCR for mouse Ucp1, human UCP1 and human PLIN1 in mouse 
adipose depots (mBAT, mIng and mEpi), human capillary-derived cells (C, MDI and 
Fsk), and adipose structures from three mice, excised 7 weeks following implantation. 
Values represent the fold difference relative to the lowest detectable value in the series 
for each respective probe set a value of 0 was given to non-detectable values. Error bars 
represent range of 2 technical replicates. 
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Figure 3.15. Multi-locular adipocytes in implants of human ‘brite/beige’ cells. 
H&E staining of adipose structure formed from implanted human cells. The adjacent 
regions of host adipose issue and implanted cells are indicated by the red dotted line 
(top), and arrows (bottom) point to examples of multi-locular cells in the sections. 
Scale bars are 200 µm (top), and 25 µm (bottom). 
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We next asked whether human ‘brite/beige’ cells could affect glucose 
metabolism. Mice implanted with cells displayed lower fasting glucose (Figure 3.16) and 
a more rapid glucose disposal rate (Figure 3.17) compared to those receiving Matrigel 
only. NSG mice have been reported to be highly resistant to high fat diet-induced 
obesity[126]. Because susceptibility to high fat diet induced obesity and glucose 
intolerance are enhanced by thermo-neutrality[127], we subjected a cohort of NSG mice 
to high fat diet at 30oC. Within 2 weeks mice displayed significant glucose intolerance 
(Figure 3.18, Left). At 2 weeks of high fat diet, mice were randomized to receive 
Matrigel or ‘brite/beige’ adipocytes as above. Seven weeks following implantation, 
glucose tolerance was higher (Figure 3.18, Right) and liver steatosis was lower (Figure 
3.19) in mice receiving cells compared to those receiving only Matrigel. Thus, 
‘brite/beige’ adipocytes derived from human capillary networks can enhance glucose 
metabolism in mice under normal conditions and in the context of impaired glucose 
tolerance. 
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Figure 3.16. Fasting glucose levels after 16 hour-fast in 
male mice implanted with Matrigel (n = 8) or cells (n = 
10).   
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17. Glucose tolerance test. 
Left: Glucose tolerance curves.  
Right: Areas under the curve (A.U.C) of the glucose excursion after 16 hour-fast in male 
mice implanted with Matrigel (n = 8) or cells (n = 10).   
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Figure 3.18. Glucose tolerance test with high fat diet. 
Left: Glucose tolerance curves after an 8 h fast in mice housed at 30 oC for 2 weeks, fed 
a normal (n = 5) or 60% high fat diet (n = 5).  
Right: Glucose tolerance curves after 11 weeks of 60% high fat diet and an 8 hour-fast in 
mice housed at 30 oC, implanted with either Matrigel (n = 5) or cells (n = 3) after 2 weeks 
of high fat diet. Statistical analysis was performed using 2-tailed unpaired Student-t tests 
at each time point of glucose tolerance curves, and Mann-Whitney test between groups 
for fasting blood glucose and area under the curves, * P < 0.05, ** P < 0.01, *** P < 
0.0001. 
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Figure 3.19. Livers from mice used in 2.18, immediately following sacrifice at 11 
weeks. Three representative livers from each group. Scale bars are 1 cm. 
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While to our knowledge this is the first description of transplanted human 
adipocytes improving systemic glucose homeostasis, it has been reported that mouse 
subcutaneous adipose tissue can improve glucose homeostasis in high fat diet-treated 
mice[128]. To determine whether the improvement in glucose tolerance seen in mice 
implanted with capillary-derived human adipocytes was indeed attributable to their 
‘brite/beige’ characteristics, we compared the effects of non-activated versus forskolin-
activated adipocytes. We used in vivo hyperinsulinemic-euglycemic clamps to measure 
whole body glucose turnover, which was normalized to circulating human adiponectin to 
adequately control for the quantity and functional integration of implanted human cells. 
Mice implanted with forskolin-activated cells displayed higher glucose turnover 
compared to those implanted with non-stimulated cells (Figure 3.20), demonstrating that 
the ‘brite/beige’ phenotype directly contributed to improved glucose metabolism. Indeed 
this value is likely to be underestimated, as adiponectin expression is higher in activated 
‘brite/beige’ adipocytes (Figure 3.9). We noted a strong correlation between serum 
human adiponectin and whole body glucose turnover when the entire cohort of mice with 
non-activated and activated cells were analyzed (Figure 3.22), suggesting that non-
activated cells were also capable of affecting glucose turnover, or that the cells became 
activated following transplantation. RT-PCR analysis of the implanted structures revealed 
detectable UCP1 expression in tissue formed from non-activated cells, albeit at lower 
levels than that seen in tissue formed from forskolin-activated cells (Figure 3.22). These 
results support the conclusion that cells derived from human capillary networks give rise 
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to ‘brite/beige’ adipocytes, which can be activated in vitro and in vivo, and can affect 
glucose homeostasis. 
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Figure 3.20. Glucose turnover (µmol/Kg/min) 
normalized to serum human adiponectin (ng/ml) in 
male mice implanted with non-stimulated (MDI, n = 5) or 
forskolin-stimulated (FSK, n = 5) adipocytes, seven 
weeks prior to hyperinsulinemic-euglycemic glucose 
clamps. Statistical analysis was performed using the 
Mann-Whitney test, *P < 0.05. 
 
 
 
 
 
 
Figure 3.21. Adiponectin v.s. glucose turnover. 
Relationship between serum human adiponectin levels 
and glucose turnover in implanted mice (n = 10). 
Linear regression P value = 0.0027, R2  = 0.601.  
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Figure 3.22. RT-PCR for human UCP1 in implanted cell structures from mice 
studied in Figure 3.20. Statistical analysis was done using unpaired 2-tailed Student t-test, 
* P < 0.05. 
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To determine whether the enhanced glucose tolerance seen in mice implanted 
with ‘brite/beige’ adipocytes was related to the thermogenic properties of these cells, 
body temperature was measured using subcutaneously implanted Thermochron iButton 
temperature loggers, which have a resolution of 0.025oC, set to record at 30 min intervals. 
Mice housed at room temperature harboring ‘brite/beige’ adipocytes did not differ 
significantly from Matrigel controls in their basal body temperature, or in their response 
to cold exposure (Figure 3.23). It remains possible that local thermogenic effects, 
undetectable by whole body temperature measurements, contribute to improved glucose 
metabolism. Alternatively, implanted cells might contribute to glucose tolerance 
independently of thermogenesis. To determine whether glucose uptake into implanted 
cells contribute to glucose turnover, we measured 2-[14C] deoxyglucose uptake into 
tissues during hyperinsulinemic-euglycemic clamps. On a per gram of tissue basis, the 
rate of glucose uptake by implanted cell structures was significantly higher compared to 
epididymal white fat, but lower than interscapular brown fat in the same animal (Figure 
3.24, Left). Because the density of cells in the implant is lower than in tissue due to 
dilution with Matrigel, these values may represent an underestimate of glucose 
consumption by human cells. Thus, improved glucose tolerance may be in part 
attributable to glucose consumption by implanted cells. However, whole body glucose 
turnover was not directly correlated with the amount of glucose uptake by the implanted 
cells (Figure 3.24, Right), suggesting that additional effects on peripheral tissues underlie 
enhanced glucose turnover. Indeed, improved metabolism attributable to brown adipose 
tissue effects on liver has been reported[129].  
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Figure 3.23. Temperature recordings from subcutaneous iButtons in mice implanted 
with Matrigel or cells 7 weeks following implantation. Arrow represents time at which 
mice were placed at 5oC. 
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Figure 3.24. Glucose uptake and turnover. 
Left: Glucose uptake into epididymal fat (WAT), interscapular brown fat (BAT) and 
implanted cell structures from mice studied in (b), n = 10. Statistical analysis was 
performed using unpaired 2-tailed Student-t tests * p< 0.05, ** P < 0.01, *** P < 0.0001.  
Right: Relationship between glucose uptake into implanted cell structures and glucose 
turnover (n = 10).  
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To explore the possibility that the metabolic benefits of human ‘brite/beige’ 
adipocytes could be due to secreted factors, we conducted global gene expression 
analysis of adipocytes before and after 7 days of forskolin stimulation (Figure 3.25). 
Unexpectedly, amongst the most significantly induced genes were the proprotein-
convertase subtilisin/kexin type-1 (PCSK1), its substrate proenkephalin (PENK), and 
interleukin 33 (IL-33). Mutations and polymorphisms in PCSK1 are strongly associated 
with human obesity[130, 131], although the underlying mechanisms are unclear. 
Cleavage of PENK by PCSK1 produces enkephalins, which are made in peripheral 
tissues in addition to the brain[132]. IL-33 has been shown to decrease adiposity, mitigate 
atherosclerosis and be necessary for normal glucose homeostasis in mouse models[133, 
134]. Interestingly, enkephalins and IL-33 have been shown to induce adipose tissue 
browning[134]; thus, production of these factors by implanted ‘brite/beige’ cells could 
explain the sustained expression of UCP1 seen weeks following implantation (Figure 
3.26). While we were not able to detect IL-33 in the circulation of transplanted mice, 
immunostaining revealed punctate structures containing IL-33 within activated 
adipocytes (Figure 3.27). Further studies will be required to determine possible autocrine 
effects of IL-33 on the induction or maintenance of the ‘brite/beige’ adipocyte phenotype 
in vivo. 
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Figure 3.25. Volcano plot of differential gene expression in adipocytes without or 
with forskolin-treatment for 7 days, indicating genes of interest such as PCSK1, IL-33, 
PENK, SPON1 and CXCL6. Fold change in forskolin-treated cells relative to non-treated 
cells. 
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Figure 3.26. RT-PCR of PCSK1, PENK and IL-33 expression in non-differentiated 
(C), differentiated (MDI), and forskolin-treated adipocytes (FSK), and perivascular 
adipose tissue (PV). Values represent fold difference over the lowest detectable value in 
the series for the respective probe set. Plotted are means and s.e.m. from 2 technical 
replicates of samples from 3 (C, MDI, FSK) or 4 (PV) individuals. 
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Figure 3.27. Expression of IL-33 in ‘brite/beige’ adipocytes. Cells isolated from 
capillary networks were sub-cultured on coverslips, grown to confluence and subjected to 
adipogenic differentiation. Differentiated cells (top left) or differentiated cells treated with 
forskolin for 7 days (bottom left), were fixed, permeabilized and stained with antibody to 
human IL-33 (green) and Hoechst (blue). Scale bars are 25 µm and 10 µm (enlargement, 
right). Arrows point to numerous vesicular structures containing IL-33. 
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Table 3. Probes used for RT-PCR 
 
Gene name                            Forward (Fw) or Reverse (Rv) probe Sequences 
Mouse UCP1 Fw  GTGAACCCGACAACTTCCGAA  
Mouse UCP1 Rv  TGCCAGGCAAGCTGAAACTC  
Human UCP1 Fw  AGAAGGGCGGATGAAACTCT 
Human UCP1 Rv  ATCCTGGACCGTGTCGTAG  
PPARGC1A Fw   TCTGAGTCTGTATGGAGTGACAT   
PPARGC1A Rv   CCAAGTCGTTCACATCTAGTTCA  
DIO2 Fw   GGATGCCCCCAATTCCAGTG  
DIO2 Rv   GGCTCGTGAAAGGAGGTCAAG  
CIDEA Fw   TTATGGGATCACAGACTAAGCGA  
CIDEA Rv   TGCTCCTGTCATGGTTGGAGA  
PRDM16 Fw   CTTCGGATGGGAGCAAATACTG 
PRDM16 Rv   TCCACGCAGAACTTCTCACTG  
Human PLIN1 Fw  ACCAGCAAGCCCAGAAGTC  
Human PLIN1 Rv  CATGGTCTGCACGGTGTATC 
ADIPOQ Fw   TGCTGGGAGCTGTTCTACTG  
ADIPOQ  Rv   TACTCCGGTTTCACCGATGTC  
LEPTIN Fw   TGCCTTCCAGAAACGTGATCC  
LEPTIN Rv   CTCTGTGGAGTAGCCTGAAGC  
PDK4 Fw   GGAGCATTTCTCGCGCTACA 
PDK4 Rv   ACAGGCAATTCTTGTCGCAAA 
CD137 Fw   AGCTGTTACAACATAGTAGCCAC  
CD137 Rv   GGACAGGGACTGCAAATCTGAT 
CITED1 Fw   CCTCACCTGCGAAGGAGGA  
CITED1 Rv   GGAGAGCCTATTGGAGATCCC  
TBX1 Fw   ACGACAACGGCCACATTATTC  
TBX1 Rv   CCTCGGCATATTTCTCGCTATCT  
TMEM26 Fw   ATGGAGGGACTGGTCTTCCTT  
TMEM26 Rv   CTTCACCTCGGTCACTCGC 
EVA1 Fw   TTAATGGGACAGATGCTCGGT 
EVA1 Rv   AAGACACCCGGTCCTTAAACC  
LHX8 Fw   GAATGACCTATGCTGGCATGT  
LHX8 Rv   ACCCAGTCAGTAGAATGGATGTG  
PENK Fw   CTGGATGGCATTGTGACGGAT  
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Gene name                             Forward (Fw) or Reverse (Rv) probe Sequences 
PENK Rv   GCCCCAGCTTGCACTGTAAA  
PCSK1 Fw   CGGTTCCTGACACTTTGCACT  
PCSK1 Rv   CACATTCCATTACGCAAGCCA  
IL33 Fw   GTGACGGTGTTGATGGTAAGAT 
IL33 Rv   AGCTCCACAGAGTGTTCCTTG  
SLC2A4 Fw   TGGGCGGCATGATTTCCTC 
SLC2A4 Rv   GCCAGGACATTGTTGACCAG 
FABP4 Fw   ACTGGGCCAGGAATTTGACG   
FABP4 Rv   CTCGTGGAAGTGACGCCTT 
RPL4 Fw   GCCTGCTGTATTCAAGGCTC  
RPL4 Rv   GGTTGGTGCAAACATTCGGC 
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Discussion  
 
 In summary, our data reveal that human adipocyte progenitor cells proliferate in 
response to pro-angiogenic stimuli in conjunction with adipose tissue angiogenesis. 
These cells display the cardinal feature of ‘brite/beige’ adipocytes, which is the near 
absence of thermogenic genes under basal condition, but their strong induction in 
response to adrenergic stimulation. To our knowledge, these findings are first to enable 
the growth and differentiation of human ‘brite/beige’ cells, and the assessment of their 
effects of systemic glucose homeostasis. These cells differ from human brown adipocyte 
cell lines established through immortalization of human precursors[102, 113] or 
differentiation of human pluripotent stem cells[104] in their highly inducible expression 
of a thermogenic phenotype, in the development of uncoupled respiration, and in their 
capacity to affect metabolism upon transplantation in vivo. 
Our finding of a functional relationship between angiogenesis and ‘brite/beige’ 
adipocyte development converges with existing studies where overexpression of the pro-
angiogenic factor VEGF in mouse adipose tissue results in extensive browning[135, 136]. 
In addition, perivascular adipose tissue surrounding major blood vessels displays 
thermogenic characteristics[137, 138], and its loss results in cold intolerance, endothelial 
dysfunction and susceptibility to atherosclerosis[137]. The finding that human 
‘brite/beige’ adipocytes enhance glucose homeostasis provides a clear rationale for their 
potential therapeutic use.  
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 Moreover, the expression of neuroendocrine and secreted factors by activated 
cells suggests that secreted products identified in these studies could also contribute to 
metabolic effects. Future studies to systematically assess the mechanisms by which 
human ‘brite/beige’ cells develop and affect glucose homeostasis will be greatly 
facilitated by the ability to generate these cells from human adipose tissue by the methods 
described herein. 	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CHAPTER IV: Exploring the distinct gene expression signatures of human brown, 
beige, white adipose-derived progenitors and adipocytes 
 
Author Contributions  
Khanh-Van Tran, Timothy Fitzgibbons, Raziel Rojas-Rodríguez, Tiffany DeSouza and 
Anand Desai 
 
Summary  
Adipose tissue plays numerous functions, some of which are restricted to regional 
depots. Differences amongst adipocytes within these depots can arise from distinct 
lineage origins, differing regional stimuli, or a combination of both. Thermogenic adipose 
tissue, defined as containing the uncoupling protein UCP1, is found in distinct depots. In 
humans, UCP1 containing adipocytes have been identified in the neck and 
supraclavicular region. To define the mechanisms involved in this specific distribution of 
thermogenic fat, we determined whether progenitors for beige adipocytes differ in 
abundance between three human depots: peri-carotid, subcutaneous from the neck, and 
subcutaneous from the abdominal region. All three depots contain adipocyte progenitors 
that proliferate in association with emerging capillary networks, and all depots contain 
beige adipocyte progenitors. This supports the notion that differences between depots are 
resulted less from clearly distinct progenitor lineages than from the local environment in 
which those progenitors differentiate. However, cells derived from these three depots 
retain a distinct identity, discerned through hierarchical clustering analyses of their 
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expressed genome. We also identify regional differences in expression level of 
LINC00473, recently shown to determine responsiveness to cAMP signaling; Levels of 
LINC00473 directly correlate with the extent of UCP1 expression in beige cells from 
different depots. These results suggest that, through genes such as LINC00473, small 
regional differences in gene expression can greatly amplify local stimuli to develop the 
substantially different functional properties associated with each adipose depot in 
humans. 
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Introduction  
 
The sheath of adipose tissue surrounding blood vessels, called perivascular 
adipose tissue (PVAT), was long considered as mechanical protection to the vessels[139] 
until the recent findings on other roles of PVAT, which include the secretion of leptin, 
adiponectin, resistin, free fatty acids, and vasoactive substances, have been 
explored[140]. Furthermore, early studies of PVAT from human coronary arteries 
unexpectedly detected expression of BAT-specific genes such as PRDM16 and UCP1 at 
an intermediate level of WAT and BAT[141]. Notably, mouse PVAT surrounding the 
abdominal aorta displays characteristics of WAT, whereas PVAT surrounding the 
thoracic aorta appears to be morphologically closer to BAT with multi-locular lipid 
droplets and abundant mitochondria[142, 143]. Our collaborator Fitzgibbon et 
al.[97]showed by microarray analysis that global gene expression profiles of mouse 
PVAT are nearly identical to BAT, with high expression of thermogenic genes (UCP1, 
Cidea, etc.) and morphological traits (multi-locular lipid droplets and abundant 
mitochondria). Moreover, in C57BL6/J mice fed with high-fat diet, PVAT and BAT 
showed markedly lower expression of inflammation-related genes, compared to that of 
WAT, which suggests these depots are resistance to obesity-induced inflammation. In 
accordance, macrophage markers (F4/80 and CD68) in BAT and PVAT of obese mice 
showed no macrophage infiltration. Chang et al. also found a similar proteomic profile 
between thoracic PVAT and BAT[144]. In their proteomics analysis of the PVAT from 
mice stimulated with a cold exposure, the authors identified virtually identical protein 
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expression profiles, which were highly related to cellular metabolic processes.  
The functional role of PVAT was discovered in a mouse model deficient of 
PPARγ in smooth muscle cells, which unexpectedly had low PVAT. These results 
uncovered that an absence of PVAT results in loss of its thermogenic capability, impaired 
vascular homeostasis that caused body temperature decrease and endothelial 
dysfunction[144]. Another recent study also suggested that at least some beige adipocytes 
may derive from smooth muscle-like precursors[66]. Using translating ribosome affinity 
purification (TRAP) technology, the authors demonstrated a smooth muscle-like 
signature expressed by beige, but not classical brown, adipocytes. In the data TRAP set, 
they further investigated Myh11, the most selective marker known for bona fide mature 
smooth muscle and other smooth muscle-like cells. Lineage tracing using either a 
constitutive or an inducible Myh11-driven Cre suggested that at least a subset of beige 
cells arise from a smooth muscle-like origin. Finally, ectopic expression of PRDM16 
converts bona fide vascular smooth muscle cells into UCP1-positive adipocytes in vitro.  
To investigate whether we can translate the PVAT characterization studies 
performed in rodent models into humans, our laboratory decided to leverage our expertise 
in generating adipocyte progenitors and adipocytes to study the differences in the 
precursor population in human brown (carotid), beige (neck subcutaneous), and white fat 
(abdominal subcutaneous) depots[110, 145].  
The proper organization of the vertebrate body requires local information in the 
embryo that can coordinate an orchestrated global pattern. The generation of targeted 
loss-of-function mutations in mice and transplantation experiments have been useful to 
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examine detailed genetic functions of Homeobox (HOX) paralogues in mammalian 
development[146]. Nowicki et al. performed heterotopic transplantation of segmental 
plate from quail to chick and clearly presented that the donor tissue retained its own HOX 
paralogue expression after transplantation, except for the abaxial domain, and the specific 
Hox gene expression correlates with axial specification[147]. Numerous studies 
investigated the correlation between the mutation of Hox genes and the consequential 
phenotypes[148], thereby concluding the patterning of Hox paralogues as following[146]: 
HOX5 (cervical, thoracic); HOX6 (cervical, thoracic, upper ribs); HOX9 (lower ribs); 
HOX10 (lumber, sacral);  HOX11 (sacral, caudal).   
Interestingly, several hormones and their receptors have been shown to regulate 
Hox gene expression. Estradiol, progesterone, testosterone, retinoic acid, and vitamin D 
have been shown to regulate Hox gene expression[149]. Vice versa, HOX genes build a 
network of transcription factors (homeoproteins) to control essential functions of adult 
cells embryonic development [150], which also include the regulation of metabolic 
processes[151]. Cantile et al. analyzed the expression of the HOX genes in different 
depots of human white adipose tissue, and found that HOX genes displayed a depot-
specific expression. Moreover, expression of the paralogues group 4 genes (HOX A4, 
HOX B4, HOX C4, and HOX D4), appeared to distinguish white and brown adipose 
tissues[150]. Regarding the Fat distribution in humans, HOXA2, HOXA3, HOXA4, 
HOXA5, HOXA9, HOXB7, HOXB8, HOXC8 are found to be down-regulated in the 
gluteal depot, while HOXA10 and HOXC13 are highly expressed[152]. Conversely, 
visceral adipocytes express higher levels of HOXA5, HOXA4, HOXC8, whereas 
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subcutaneous fat showed higher levels of HOXA10, HOXC9, TBX15 and SHOX2[153]. 
The expression of HOXC8 is highly enriched in brown adipose tissue[154]. Remarkably, 
HOX genes are shown to play roles in metabolic diseases. For example, the contribution 
of multiple variants at POU class 2 homeobox 1 (POU2F1), also known as octamer-
binding transcription factor-1 (OCT1), to the risk of Type 2 diabetes has been 
established[155]. Hyper-expression of HOXA5 induces an increase in insulin-like growth 
factor binding protein1 (IGFBP1), which has a crucial role in adipocyte biology and 
metabolism[156]. The interplay between Hox and hormones orchestrates the function of 
adult organs in specific locations as well as the developmental program, thus implying 
the potential roles of Hox genes in human brown and brite/beige adipose tissues 
maintenance in various anatomical locations. 
Long-noncoding RNAs (lncRNAs) have recently gained widespread attention as a 
crucial player of biological regulation. LncRNAs function as modular molecules with 
individual domains[157]. The embedded motifs in the lncRNA sequences enable the 
RNA to specifically bind with DNA, RNA or protein. Both mis-expression and mutations 
of lncRNAs is linked to numerous diseases[158]. Taking just few examples, Finnish 
subjects with type 2 diabetes possessed a large number of single nucleotide 
polymorphisms in the INK4/ARF loci, which is associated with increased risk of type 2 
diabetes[159]. Also, a chromosomal translocation (1;11)(q42.1; q14.3) was identified to 
be strongly associated with schizophrenia and other neuropsychiatric disorders, directly 
affecting DISC1 and DISC2 (disrupted in schizophrenia 1 and 2)[160]. DISC2 encodes 
the lncRNA that is antisense to DISC1 and it is postulated that DISC2 is involved in 
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regulating expression of DISC1. The suggested mechanisms of how lncRNAs may 
function in their biological roles include disrupting translation, working as a 
transcriptional co-activator, forming functional nuclear bodies, looping chromatin, 
masking splice sites, competing with microRNAs, increasing mRNA stability, localizing 
transcriptional factors and decreasing mRNA stability[161].  
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Materials and methods  
 
General Methodology. No samples, mice or data points were excluded from the reported 
analyses. Samples were not randomized to experimental groups except where indicated. 
Analyses were not performed in a blinded fashion except where noted below.  
 
Materials. Matrigel from BD biosciences (56231); EGM-2 MV from Lonza; Forskolin 
from Sigma (F3917).  
 
Adipose Tissue. Among the human thermogenic depots, we collected carotid peri-
vascular (human brown) and neck subcutaneous (human beige), adipose tissues from 
carotid endarterectomies with no a-priori selection of individual donors. All specimens 
were collected after informed consent in accordance with procedures approved by the 
University of Massachusetts Institutional Review Board. The characteristics of patients 
from which tissues were used for indicated experiments are described in Table 3.  
 
Explants. Detailed methods for harvesting adipose tissue, culture of adipose tissue 
explants in Matrigel are published[96]. In brief, explants from human subcutaneous 
adipose tissue were cultured in EBM-2 media supplemented with endothelial growth 
factors (EGM-2 MV) (Lonza). In indicated experiments, Dulbecco’s Modified Eagles 
Medium (Gibco) supplemented with 10% fetal bovine serum (DMEM-FBS) was used, 
without or with supplementation with VEGF (vascular endothelial growth factor), hFGF-
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B (human fibroblast growth factor B), hEGF (human epidermal growth factor), R3-IGF-1 
(long R3 insulin-like growth factor 1) at the concentrations used in EGM2-MV, as 
indicated. To induce adipogenesis we used a minimal adipogenic cocktail of DMEM 
+10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 1 µM dexamethasone, and 1 µg/ml 
insulin (MDI) for 72 hours. The medium was then replaced with DMEM plus 10% FBS. 
Subsequently, 50% of the medium was replaced with fresh medium every other day. 
Adipocyte markers were measured by RT-PCR in RNA extracted from 3 explants per 
condition.  
 
Cells. Detailed methods for harvesting adipose tissue, culture of adipose tissue explants 
in Matrigel, and harvesting of single cells from explant growth are published[96]. In 
brief, explants from human subcutaneous adipose tissue were cultured in EBM-2 media 
supplemented with endothelial growth factors (EGM-2 MV) (Lonza) for 14 days. Single 
cells suspensions from capillary growth (capillary network cells) were obtained using 
dispase[96], and plated on standard tissue culture plates. Growth and passaging of these 
cells was done using EGM-2 MV. Where indicated, adipogenic differentiation was 
induced by replacement of EGM-2 MV by DMEM +10% FBS, 0.5 mM 3-isobutyl-1-
methylxanthine, 1 µM dexamethasone, and 1 µg/ml insulin (MDI). 72 hours later, the 
differentiation medium was replaced by DMEM-FBS, which was replaced every 48 hours 
until analysis. In experiments to investigate the effects of ‘brite/beige’ adipocytes in vivo, 
cells from capillary networks were grown to confluence into 150 mm dishes, 
differentiated using MDI for 10 days, and browning induced for 7 days with forskolin. 
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RT-PCR. Adipocyte markers were measured by RT-PCR in RNA extracted from one 
well of a confluent 6 well multi-well dish of cells. Adipocyte markers were measured in 
RNA extracted from 3 explants per condition, or from one well of a confluent 6 well 
multiwell dish of cells. Probe sets used are shown in Table 3. 
 
Affymetrix arrays. Total RNA was isolated using TRIzol. Affymetrix protocols were 
followed for the preparation of cRNA, which was hybridized to HTA-2.0 arrays. Raw 
expression data collected from an Affymetrix HP GeneArrayScanner was normalized 
across all data sets using the RMA algorithm as implemented by the Affymetrix 
Expression Console. Expression analysis was performed using the Affymetrix 
Transcriptome Analysis Console v.3.0. The data discussed in this publication have been 
deposited in NCBI's Gene Expression Omnibus and are accessible through GEO Series 
accession number GSE73385. 
 
Statistical analyses. RT-PCR results are presented as means of technical replicates with 
error range indicated. Experiments shown are representative, and have been repeated a 
minimal of 3 times per depot with cells derived from different individuals, with no a 
priori selection. Software employed was GraphPad Prism v.6. To compare groups with 
normally distributed values, 2-tailed unpaired Student t-tests were used. When normality 
could not be determined, the Mann-Whitney test was used. Data are presented as mean 
values ± s.e.m. or range between technical replicates when experiments were 
representative, as indicated in each figure legend. P-values are indicated in each case.  
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Table 4. Patient Characteristics (Carotid endarterectomy) 
Collected 
Fat 
Tissues 
Surgery 
Procedure Gender Age BMI T2DM HTN 
Carotid 
Carotid 
endarterectomy 
Female 74 31 No Yes 
Carotid 
Neck SQ 
Carotid 
endarterectomy 
Female 77 30 Yes Yes 
Carotid 
Neck SQ 
Carotid 
endarterectomy 
Female 82 24 No Yes 
Carotid 
Neck SQ 
Carotid 
endarterectomy 
Female 65 26 No Yes 
SQ: subcutaneous; BMI: Body Mass Index; T2DM: Type 2 Diabetes Mellitus; HTN: 
Hypertension. 
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Results  
 
 Embedded adipose tissue explants from both carotid peri-vascular (PV) and neck 
subcutaneous (SQ) sprouted capillary cells in EGM-2 MV, which appeared to be similar 
to the observation with abdominal SQ from panniculectomies (Chapter II). Isolated 
capillary cells were plated on dishes and differentiated into adipocytes in the same way as 
described in Chapter II. Morphology of the adipocytes from PV and SQ looked virtually 
identical except for the slightly larger adipocyte size from SQ progenitor cells (Figure 
4.1). Upon 7-days of forskolin treatment on differentiated capillary cells from each depot, 
both PV and SQ induced UCP1 mRNA expression (Figure 4.2). There was a trend of 
higher UCP1 in PV compared to SQ for both preadipocytes and adipocytes without 
statistical significance. Based on the results from earlier chapters and this result, it is 
likely that brite/beige adipocyte progenitors can originate from multiple depots in human, 
including all three white, brite/beige, and brown adipose tissues without much difference 
in their progenitor population and the potential to be induced as thermogenic fat. These 
data suggest that environmental cues in the specific location of the body might be a more 
important controlling factor to explain the anatomical distribution of human brown and 
brite/beige depots. 
Nevertheless, global gene expression profile revealed the progenitor populations 
from different depots can be distinguished from each other (Figure 4.3). We compared 
the transcriptome signatures of adipose progenitors derived either from human carotid 
peri-vascular (Carotid), neck subcutaneous (NeckSQ), or abdominal subcutaneous 
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(AbdSQ). Heat map from the transcriptome array using genes that differed at an ANOVA 
P value of 0.001 clearly clustered the biological triplicates of each depot together, 
suggesting tissues from different anatomical sites have specific transcriptome patterns. 
Assuring our data represent biologically relevant results, patterning gene SHOX2 was 
expressed abundantly in the AbdSQ samples, which confirms the previous findings that 
subcutaneous fat shows higher SHOX2[153] although HOX10, which is known to have a 
higher expression level in subcutaneous adipose tissue[153], was not abundant in the 
AbdSQ samples. HOX6, another HOX gene found to be highly expressed in cervical, 
thoracic and upper rib regions[146], was abundantly expressed in our Carotid samples in 
accordance with previous studies.    
To determine whether any of the differentially expressed genes might contribute 
to depot-specific functional differences, we performed cluster analysis on a set comprised 
of differentiated cells from each depot, with and without forskolin stimulation (Figure 
4.4). Comparison of adipocytes and forskolin-induced adipocytes generated from three 
depots revealed that forskolin-treated Carotid and NeckSQ clustered together, being the 
farthest and the most different from AbdSQ as expected. Next, control Carotid and 
control NeckSQ clustered together while AbdSQ and AbdSQ+Fsk clustered together, 
implying abdominal adipocytes are significantly dissimilar from neck fat-derived 
adipocytes, regardless of forskolin-treatment. Most importantly, in all groups three 
biological replicates from individual patients were clustered together, indicating 
biological differences in progenitors from each depot and their response to forskolin 
prevail over individual variances.   
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One of the most distinctive clusters comprised the genes LINC00473, AREG, 
NR4A2, RELL1, SLC6A15 and WNT5A (Figure 4.4). Among these genes, LINC00473 
drew our attention due to the recent study demonstrating the role of LINC00473 in one of 
the pathways that is involved in adrenergic stimulation. Chen et al. found that 
LINC00473 facilitates CRTC/cyclic AMP-responsive element-binding protein (CREB)-
mediated transcription in non-small cell lung cancers[162]. In brown adipocytes, cold and 
sympathetic stimulation works through β3-adrenergic receptor-cAMP-CREB/ATF2 
pathway to induce BAT-enriched genes, including UCP1[57]. The mRNA expression 
level of LINC00473 was confirmed by RT-PCR, which strongly correlated with UCP1 
expression in adipocytes and even in preadipocytes (Figure 4.5), generated from PV, 
NeckSQ and AbdSQ. In human adipose tissues, abundance of brite/beige adipocytes in 
different depots may result from expression of factors such as LINC00473 that could 
modulate sensitivity to catecholamines. 
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Figure 4.1. Morphology of differentiated capillary cells derived from human carotid 
peri-vascular (PV) and neck subcutaneous (SQ). 
 
  
Figure 4.2. UCP1 expression in 
preadipocytes and adipocytes 
derived from neck fat depots 
with or without forskolin. 
Values represent fold difference 
over the lowest detectable value 
in the series for the respective 
probe set. Plotted are means of 
UCP1 expression relative to 
PLIN1, normalizing UCP1 
expression by number of 
adipocytes to compensate the 
variance in differentiation, and 
s.e.m. from 2 technical replicates 
of samples from 3 PV and 3 SQ 
individuals. 
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Figure 4.3. Heat map comparing the 
progenitors derived from Carotid, 
NeckSQ and AbdSQ. 
Top: Heat map from Affymatrix HTA 2.0 
array comparing the transcriptome 
signature of adipose progenitors derived 
from human carotid peri-vascular 
(Carotid), neck subcutaneous (NeckSQ), 
and abdominal subcutaneous (AbdSQ). 
The biological triplicates of each depot 
were clustered together.  
Bottom: Enlarged heat map for patterning 
HOX genes. 
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Figure 4.4. Heat map comparing the adipocytes derived from Carotid, NeckSQ and 
AbdSQ with or without forskolin-treatment. 
Top: Heat map comparing differentiated adipocytes and forskolin-induced (+Fsk) 
adipoctyes derived from human carotid peri-vascular (Carotid), neck subcutaneous 
(NeckSQ), and abdominal subcutaneous (AbdSQ). 
Bottom: Enlarged area in the heat map, displaying upregulared genes in the most 
thermogenic conditions such carotid+Fsk and neck SQ+Fsk.  
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Figure 4.5. LINC00473 expression correlated with the level of UCP1 
Top and bottom right: RT-PCR for LINC00473 on pre-adipocytes, adipocytes and 
forskolin-treated adipocytes (Adipocytes+Fsk), derived from human carotid peri-vascular 
(Carotid), neck subcutaneous (NeckSQ) and abdominal subcutaneous (AbdSQ). 
Technical triplicates. N=3.  
Bottom left: The strong positive correlation between UCP1 and LINC00473 mRNA 
expression. Values represent pre-adipocytes, adipocytes and adipocytes+Fsk from 
Carotid, NeckSQ and AbdSQ. 
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Discussion  
 
In this chapter, we analyzed the global gene expression profile of progenitors and 
adipocytes from three human adipose depots that are considered to be representative of 
brown, beige and white fat: peri-carotid (brown), neck subcutaneous (beige) and 
abdominal subcutaneous (white). The results from chapter II, III and IV clearly 
demonstrate that all three depots contain adipose progenitor population that can give rise 
to thermogenic fat cells. However, the gene array data revealed their differences in global 
gene expression level, suggesting the progenitor population from each depot is distinct. 
The data also discovered several potential thermogenic regulators (e.g. LINC00473), 
which could explain the variations in thermogenic capacities of different adipose depots 
relating to their physiological locations.  
Non-coding RNAs fundamentally contribute to the regulation of gene expression 
in brown and beige adipocytes. MicroRNAs (miR) such as miR-133, miR-193b, and 
miR-365 target PRDM16 and decrease brown and beige adipocyte development in 
mice[163, 164]. miR-196a represses HoxC8, a negative regulator of C/EBPβ, resulting in 
induction of beige adipocyte differentiation[165] Similarly, long non-coding RNAs also 
provide another layer of regulation; for example, Inc-BATE1 and Blinc1 are required for 
brown and beige adipocyte differentiation through formation of a nuclear 
ribonucleoprotein complex that controls the thermogenic gene expression[166, 167] 
(Alvarez-Dominguez et al., 2015; Zhao et al., 2014). A long non-conding RNA 00473, on 
which I discussed in this chapter, was recently reported by Chen et al. LINC00473 was 
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induced by LKB1 inactivation in a lung cancer cells, leading to the subsequent 
CREB/CREB-regulated transcription co-activator (CRTC) activation. The authors 
showed that LINC00473 is a nuclear lncRNA that interacts with NONO, a component of 
the cAMP signaling pathway, thereby facilitating CRTC/CREB-mediated transcription 
(Figure 4. 9)[162]. Further studies including genetic manipulation of LINC00473 in 
human preadipocytes and adipocytes will be useful to understand the biology of 
LINC00473 in human adipocytes.  
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Chapter V: Concluding remarks and future directions 
 
Concluding remarks: capillary networks as a niche of human white, brown and 
brite/beige adipocyte progenitors 
In the efforts to answer the questions that I addressed earlier in the Project Goals, 
this thesis led to these findings: 1) in vitro adipose tissue angiogenesis system generates 
human adipocyte progenitors, which can be readily isolated and further expanded. These 
adipose progenitor cells have the potential to differentiate into adipocytes, which makes 
this advancement valuable to researchers and clinicians in the field. 2) The isolated 
adipose progenitors with or without in vitro differentiation are able to form a fat pad in 
vivo, which can be successfully vascularized and integrated into mouse circulatory 
system. 3) The capillary-associated origin of human brite/beige adipocyte is discovered. 
Functional brite/beige adipocytes can be generated from capillary-derived adipocyte 
progenitors of human subcutaneous white adipose tissue. 4) When transplanted into 
humanized mice, human brite/beige adipocytes show strong effects on whole body 
metabolism. 5) Human brite/beige adipocytes produce neurocrine and secretory proteins 
(e.g. IL-33, PCSK1, PENK) that may mediate effects on systemic metabolism. 6) The 
global transcriptome analysis reveals the distinct signatures of the progenitors and 
adipocytes of human brown (carotid perivascular), brite/beige (neck subcutaneous) and 
white (abdominal subcutaneous) adipose tissue. 7) The gene array analysis identifies 
LINC00473 as a potential thermogenic regulator. Major findings are summarized in the 
Figure 5.1. 
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The identification and development of a robust adipose stem cell population is 
attracting great attention due to the strong need for tissue replacement and regeneration in 
human patients. “Adipose-derived stem cells”-enriched lipo-transfer has markedly 
improved the survival of transplanted fat as well as decreased adverse effects in human 
patients. However, the limited expandability and the differentiation potential of adipose-
derived stem cells still require the development of advanced adipogenic adipose stem 
cells. In this thesis, the results in chapter II show that better enriched human adipocyte 
progenitors can be generated by expanding adipose tissue capillary networks under pro-
angiogenic stimuli. Furthermore, capillary-derived adipocytes recapitulate the 
characteristics of human primary adipocytes and form a vascularized fat pad when put 
into Nude mice. Comparison between adipose subcutaneous capillary cells and 
conventional adipose-derived stem cells suggests that capillary-derived adipocyte 
progenitors retain higher viability and superior differentiation potential. The development 
of improved harvesting and expanding methods for adult adipose stem cells in this thesis 
may advance the use of these adipose stem cells in clinical applications (e.g. fat 
transplantation, reconstruction, wound repair). Also, further investigation of the 
mechanism by which capillary-derived adipose stem cells expand will be immensely 
useful in optimizing the production process of the adipose stem cells.  
The results described in chapter III and IV indicate that brite/beige cells can be 
generated from multiple fat tissues in vitro, differentiated into beige adipocytes, and 
implanted back into the humans for a therapeutic use. Up to date, main challenges in 
leveraging browning to enhance insulin insensitivity include that thermogenic fat is 
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scarce in obese or diabetic patients, and that the thermogenic depots need to be activated. 
One approach can be to increase the amount of functional thermogenic fats by recruiting 
more beige cells that are metabolically active using environmental or pharmacological 
agents. So far, numbers of pharmacologic activators of the β-­‐adrenergic	  pathway	  have 
been tested but failed due to the lack of efficacy in obese populations or adverse effects 
(e.g. elevated blood pressure and heart rate)[168]. Another approach can be activating 
endogenous thermogenic fat in human. One recent example of this attempt is 
demonstrated by Cypess et al.[107] where β-­‐adrenergic	  receptor	  agonist	  Mirabegron 
shows acutely enhanced glucose uptake of brown fat in human subjects. The findings in 
this thesis that multiple human adipose depots contain the progenitors of recruitable and 
inducible thermogenic adipocytes validate the idea of boosting browning as a therapeutic 
use. The new method to generate human brite/beige adipocyte progenitors developed in 
this thesis not only provides the necessary material to study but also suggests a possible 
way of producing metabolically beneficial fat cells for clinical applications. 
Fundamentally, the knowledge from this thesis and further investigation on expansion, 
characteristics and function of human brite/beige fat cells will enable us to eventually 
discover specific and safe new targets for browning to achieve metabolic health in 
humans.  
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Figure 5.1. Summary of the findings. Beige adipocytes subcutaneously transplanted 
into mice improved glucose homoeostasis. Once cultured on Matrigel with angiogenic 
growth factors, the WAT explant undergoes vascular sprouting with new capillaries made 
up of endothelial cells and perivascular cells expressing stem cells and/or pericyte 
markers. The differentiation in vitro of these capillary-derived cells in the presence of 
adipogenic factors and, subsequently, the pharmacological browning compound forskolin 
gives rise to functional beige adipocytes. Once transplanted into high fat diet-fed obese 
mice (immune-deficient NOD-scid IL2rgnull mice) for 2 weeks, systemic glucose tolerance 
is improved. The authors also find PCSK1 and IL-33 to be potential molecular regulators 
of beige adipocyte functionality and the maintenance of the beige/brite phenotype. 
Pellegrinelli, V. and A. Vidal-Puig, Deriving functional beige fat from capillaries. Nat 
Med, 2016. 22(3): p. 234-236. 	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Future directions I: clonal-level transcriptome analysis on adipogenic progenitors  
The finding in this thesis that human pre-adipocytes can be isolated and expanded 
from in vitro formed capillary networks, without the need of transformation, enables the 
in depth analysis of unaltered primary human adipose progenitors. The profound 
advancement of deep sequencing and bioinformatics platforms also facilitates the 
classification of progenitor cells using very low RNA input. As a future study, we aim to 
address the question of whether white and beige adipocytes emerge from the same or 
distinct adipocyte progenitors, and if so identify specific markers that characterize each 
progenitor type. The outcome will allow us to identify beige-specific signaling pathways 
or transcriptional patterns that may be targetable for therapeutic intervention. This 
information will also provide the basis for clinical studies to determine whether metabolic 
disease is associated with defects in specific mechanisms that induce browning. Single-
cell cloning and low input RNA-seq approaches will allow us to address these questions. 
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Methods and results of preliminary studies: 
To determine whether single adipocyte progenitors are capable of autonomous 
growth and differentiation, live single cells were individually sorted into wells of 384-
well plates. In brief, to obtain clonal populations, single cells suspensions were obtained 
from capillary network cell cultures using trypsin, stained with 7-amino-actinomycin D 
(7-AAD) for live/dead cell identification, and sorted into individual wells of 384 well 
multi-well plates using a BSL3 BD FACSAria Cell Sorter (BD Biosciences). Clones 
were grown and expanded using EGM-2 MV. Viable clones were passaged onto 96 well 
multi-well plates and differentiated as described in Chapter II and III.  
As expected from cells of non-hematopoietic lineage, these cells were CD45 – 
(Figure 5.2). Surviving colonies (approximately 10% of seeded wells) could be further 
passaged into 96 well multi-wells; of these, approximately 75% underwent adipogenic 
differentiation, as determined morphologically by lipid droplet accumulation (Figure 5.3), 
and functionally by secretion of adiponectin into the culture medium (Figure 5.4). Thus, 
human adipocyte progenitors isolated from capillary networks can be clonally expanded, 
and can undergo differentiation in an autonomous manner. Notably, there was a subset of 
the population that can become adipocytes, which define them as adipocyte progenitor 
cells, among these capillary cells. Thus, further investigation into the each clone was 
followed as below to identify the adipose progenitor population(s). 
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Figure 5.2. Single-cell sorting of capillary cells. FACS sorting of live (7-AAD 
negative) singlet cells from capillary networks. CD45-FITC positive population was less 
than 0.1 % of total live cells. Single cell (CD45-negative) per well was sorted on 384 
multi-well plates.  
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Figure 5.3. Morphology of differentiated clones. Examples of one non-adipogenic and 
three adipogenic clones, identified by lipid droplet contents. Scale bars are 50 µm.  
 
 
 
 
 
 
 
Figure 5.4. Adiponectin production from clones. 
Human adiponectin concentration (ng/ml) detected 
in culture medium from 3 non-adipogenic and 3 
adipogenic clones by human-specific ELISA. 
 
 
 
 
 
	   115	  
Strategy for obtaining total RNA from adipocyte progenitors: 
Based on the preliminary results, the planned experimental scheme is suggested 
below (Figure 5.5). I expanded and differentiated the single cells clones of capillary cells 
and treated forskolin for 7 days, following the scheme. Out of total 3840 wells sorted, 
approximately 3% (118 clones) survived and successfully proliferated. Among these 
expandable clones, 86% (102 clones) reached confluence and were subjected to 
adipogenic differentiation protocol. It is noteworthy that the percentage of adipocytes in 
each well varied significantly despite the fact that all wells started with a single cell and 
expanded in the same way and we also observed several different shapes of adipocytes 
(Figure 5.6). Remarkably, the morphology of adipocytes with or without forskolin 
(Figure 5.6) suggested that not all clonal adipocytes respond to forskolin, discerned by 
their size of lipid droplets though the interpretation cannot be conclusive until we analyze 
the gene expression profile. However, it appears that there is a possibility of having 
distinct subtypes of human adipocytes among the clones.  
Total RNA has been isolated using NucleoSpin RNA XS (Macherey-Nagel, 
740902) from clonally expanded replica cells at the pre-adipocyte stage, at 
differentiation, and at stimulated stage with forskolin. The quality of RNA was analyzed 
on Fragment Analyzer (Advanced Analytical) using High Sensitivity RNA Analysis Kit 
(Advanced Analytical, DNF-472). Excluding the wells with dying cells at the time of 
collection, the isolated RNAs were intact and pure (RQN above 9 in most clones) with a 
good amount (at least 150~250 ng available per sample) to proceed to the next step. 
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As a next step, I will prepare RNA-seq library using SMART-Seq v4 3’ DE Kit 
(Clontech, 635040) for the selected clones (healthy, adipogenic, good RNA quality) at 
the pre-adipocyte and adipocyte stages. Low-input RNA-seq will determine whether the 
UCP1-inducing beige clones are genetically distinct from the clones devoid of UCP1 
induction.  
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Figure 5.5. Experimental scheme of clonal RNA-seq. On day 1, single cells collected 
from capillary sprouts are sorted into individual wells of a 384 well multi well plate. 
After approximately 14 days, viable clones that have reached near confluence are split 
into 4 wells. After approximately 7 days, one well is harvested to extract RNA. The 
remaining three wells are monitored until they reach post-confluence, and adipogenic 
differentiation is then induced using MDI. After 10 days, adipogenic clones are identified 
and RNA extracted from one of the three wells. The remaining two wells are subjected to 
chronic stimulation by forskolin. After 10 days, RNA is extracted from one of the two 
wells. The remaining well is fixed and stained for the presence of UCP1. The signal is 
used to identify which of the clones from which RNA was previously collected 
corresponded to white or beige pre-adipocytes and differentiated adipocytes. In this way, 
previously harvested clones can be identified as progenitors for either “white” or “beige” 
adipocytes. After collection of RNA from 100 white pre-adipocyte clones and 100 beige 
pre-adipocyte clones, and from their corresponding white and beige adipocytes, RNA-seq 
and bioinformatics analysis will be performed. Adapted from a NIH grant proposal of 
Corvera laboratory. 
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Figure 5.6. Morphology of differentiated clones with or without forskolin-treatment. 
Each number on the picture represents the identifier for each clone. In each clone, left 
panel shows without forskolin and right panel shows with forskolin-treatment.  
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Sequencing and bioinformatics approach to determine whether “white” and “beige” 
adipocytes originate from distinct pre-adipocytes:  
(Adapted with some modifications from a NIH grant proposal of Corvera laboratory)  
The current pipeline consists of the following steps: (i) Sequence reads are 
evaluated for overall quality using the FastQC suite (http://www.bioinformatics.-
babraham.ac.uk/projects/fastqc/), and trimmed whenever average base quality scores at 
either end are below 20. (ii) Trimmed, high quality reads are mapped to the rat ribosomal 
RNA using bowtie2 [169] to estimate ribosomal contamination and to eliminate reads 
mapping to the ribosome from further processing. (iii) non-ribosomal reads are used to 
estimate gene expression using the RSEM program [170], which implements a 
probabilistic approach of read to isoform assignment to compute isoform level counts. 
(iv) For small input libraries we concentrate on gene level counts estimated by RSEM as 
an input for differential expression analysis using DESeq [133] Markers enriched in 
PCA-defined clusters will be used to further enrich for specific cell populations, followed 
by subsequent rounds of RNA-seq and refinement of genetic identity of progenitor cells. 
Based on the lineage tracing studies in mouse, adipocyte progenitors that give rise 
to white, beige and brown adipocytes are distinct[86, 171-175]. Hence, we expect, also in 
human adipose tissues, to distinguish differential genetic signatures in progenitors of each 
adipocyte type. However, it is possible that a discrete segregation into clusters will not be 
seen if our sequencing depth does not allow detecting lowly expressed transcripts. If so, 
we will maximize sequencing reads to pick up the even subtle differences in gene 
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expression. If no clustering is seen even with this strategy, this might represent a 
stochastic process. 
 
Future Directions II: the possible metabolic functions of secretory factors produced 
by brite/beige adipocytes   
(Some contents are adapted with modifications from a NIH grant proposal of Corvera 
laboratory) 
As we better understand the physiological roles of brown and beige adipocytes, it 
is becoming clear that these thermogenic adipose tissues are not mere heat-generating 
organs. Significant improvements in glucose and lipid homeostasis by the activated 
thermogenic adipocytes may not be entirely mediated by UCP1. 
To investigate the possible mechanisms by which human capillary-derived beige 
adipocytes affect systemic metabolism, in Chapter III of this thesis, we conducted global 
gene expression analysis of the adipocytes before and after forskolin-treatment. Notably, 
among the 20 most highly induced genes in response to forskolin were the proprotein-
convertase subtilisin/kexin type-1 (PCSK1) and its substrate proenkephalin (PENK) 
(Figure 5.6, Graph). Mutations in PCSK1 are strongly associated with human 
obesity[131, 176-184] and it cleaves pro-hormones including pro-insulin, POMC and 
PENK, producing numerous bioactive peptides and enkephalins in various tissues [132, 
185, 186]. These findings collectively raise the possibility that PCSK1 may underlie the 
relationship between the presence of thermogenic adipose tissue in lean and healthy 
humans. Enkephalins whose precursor is PENK are potent activators in the central 
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nervous system and peripheral tissues, and recent findings suggest that enkephalins affect 
energy metabolism[134]. In addition to PCSK1 and PENK, the human beige adipocytes 
express mRNAs for other secreted proteins (Figure 5.6, Table). A remarkable example is 
IL-33, which has been demonstrated to decrease adiposity, mitigate atherosclerosis and 
be necessary for normal glucose homeostasis in rodents[133, 134].  
As future directions, we propose to further test whether the human beige cells do 
secrete these peptides and interleukins, resulting in a physiologically bioactive level in 
vivo. In brief, we will perform ELISA and proteomic analysis using LTQ Orbitrap Mass 
Spectrometry to investigate the secreted proteins of interest (e.g. enkephanlins, IL-33) 
and global secretome of these cells, which may allow us to identify the potential pro-
hormones that are substrates to PCSK1. In the preliminary experiments, the collected in 
vitro culture media from human beige cells were frozen, lyophilized to a volume of 2 ml 
and applied to a pre-equilibrated C18 reversed-phase liquid chromatography column to 
enrich small hydrophobic peptides. Adsorbed peptides were eluted with 80% acetonitrile, 
and run through a LTQ Orbitrap Mass Spectometer. MS/MS analysis verified the 
presence of secreted PCSK1 (D6RJA3) exclusively in the forskolin-treated samples and 
two additional secreted proteins of unclear function, TICN1/SPOCK1 and TMEM263 
were identified. Because this convertase is packaged into secretory vesicles and 
proteolytically processed into an active form, the finding of PCSK1 peptides in the 
culture medium is also strongly suggestive of functional PCSK1 activity in human beige 
adipocytes. The knowledge to be achieved by these suggested works will bolster the basic 
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understanding of the mechanism through which human beige adipocytes and their 
secreted factors enhance whole body homeostasis. 
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Figure 5.7.  List of the genes encoding potential secretory proteins from human 
beige adipocytes 
Top: Scatter plot of gene expression levels in differentiated cells without (control) or 
with forskolin-treatment for 7 days, indicating genes of interest outside the linear 
regression 95% prediction band. 
Bottom: A summary of most highly up-regulated secretory factors by forskolin-
treatment. 
 	  
Name Symbol Fold difference (FSK/MDI)p value
vasohibin 2 VASH2 17.39641927 0.0116559
spondin 1 SPON1 12.89354591 0.00918132
tachykinin, precursor 1 TAC1 10.9756317 0.0153774
amphiregulin AREG 10.7177511 0.0198066
chemokine (C-X-C motif) ligand 6 CXCL6 8.676803504 0.00067798
proprotein convertase subtilisin/kexin type 1 PCSK1 8.592670054 0.00189798
platelet factor 4 variant 1 PF4V1 8.202188132 0.0139934
proenkephalin PENK 7.505035253 0.0184174
secreted frizzled-related protein 4 SFRP4 6.794224687 0.0293923
interleukin 33 IL33 6.615438344 0.0229864
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